cardiology Flashcards

1
Q

what is Wolff-Parkinson White (WPW) syndrome

A

Wolff-Parkinson White (WPW) syndrome is caused by a congenital accessory conducting pathway between the atria and ventricles leading to a atrioventricular re-entry tachycardia (AVRT). As the accessory pathway does not slow conduction AF can degenerate rapidly to VF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ecg features of Wolff-Parkinson White (WPW) syndrome

A

Possible ECG features include:

short PR interval
wide QRS complexes with a slurred upstroke - 'delta wave'
left axis deviation if right-sided accessory pathway*
right axis deviation if left-sided accessory pathway* *in the majority of cases, or in a question without qualification, Wolff-Parkinson-White syndrome is associated with left axis deviation

Differentiating between type A and type B

    type A (left-sided pathway): dominant R wave in V1
    type B (right-sided pathway): no dominant R wave in V1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

associations of Wolff-Parkinson White (WPW) syndrome

A

Associations of WPW

   hypertrophic cardiomyopathy
    mitral valve prolapse
    Ebstein's anomaly
    thyrotoxicosis
    secundum ASD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is Ebstein’s anomaly

A

Ebstein’s anomaly is a congenital heart defect in which the septal and posterior leaflets of the tricuspid valve are displaced towards the apex of the right ventricle of the heart.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

management of Wolff-Parkinson White (WPW) syndrome

A

Management

definitive treatment: radiofrequency ablation of the accessory pathway
medical therapy: sotalol**, amiodarone, flecainide

**sotalol should be avoided if there is coexistent atrial fibrillation as prolonging the refractory period at the AV node may increase the rate of transmission through the accessory pathway, increasing the ventricular rate and potentially deteriorating into ventricular fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The European Society of Cardiology published updated guidelines on the management of atrial fibrillation in 2012. They suggest using the CHA2DS2-VASc score to determine the most appropriate anticoagulation strategy. This scoring system superceded the CHADS2 score. what are its contents and recommended anticoagulations

A
C	Congestive heart failure	1
H	Hypertension (or treated hypertension)	1
A2	Age >= 75 years	2
D	Diabetes	1
S2	Prior Stroke or TIA	2
V	Vascular disease (including ischaemic heart disease and peripheral arterial disease)	1
A	Age 65-74 years	1
S	Sex (female)	1

0 No treatment is preferred to aspirin
1 Oral anticoagulants preferred to aspirin; dabigatran is an alternative
2 or more Oral anticoagulants; dabigatran is an alternative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what drugs are used to cardiovert someone in AF?

The Royal College of Physicians and NICE published guidelines on the management of atrial fibrillation (AF) in 2006. The following is also based on the joint American Heart Association (AHA), American College of Cardiology (ACC) and European Society of Cardiology (ESC) 2012 guidelines

A

Agents with proven efficacy in the pharmacological cardioversion of atrial fibrillation

    amiodarone
    flecainide (if no structural heart disease)
    others (less commonly used in UK): quinidine, dofetilide, ibutilide, propafenone

Less effective agents

    beta-blockers (including sotalol)
    calcium channel blockers
    digoxin
    disopyramide
    procainamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why did the guidelines on the diagnosis of hypertension change in 2011

A

It has long been recognised by doctors that there is a subgroup of patients whose blood pressure climbs 20 mmHg whenever they enter a clinical setting, so called ‘white coat hypertension’. If we just rely on clinic readings then such patients may be diagnosed as having hypertension when the vast majority of time there blood pressure is normal.

This has led to the use of both ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM) to confirm the diagnosis of hypertension. These techniques allow a more accurate assessment of a patients’ overall blood pressure. Not only does this help prevent overdiagnosis of hypertension - ABPM has been shown to be a more accurate predictor of cardiovascular events than clinic readings.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hypertension classification

A

Stage 1 hypertension Clinic BP >= 140/90 mmHg and subsequent ABPM daytime average or HBPM average BP >= 135/85 mmHg

Stage 2 hypertension Clinic BP >= 160/100 mmHg and subsequent ABPM daytime average or HBPM average BP >= 150/95 mmHg

Severe hypertension Clinic systolic BP >= 180 mmHg, or clinic diastolic BP >= 110 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

diagnosis of hypertension

A

Firstly, NICE recommend measuring blood pressure in both arms when considering a diagnosis of hypertension.

If the difference in readings between arms is more than 20 mmHg then the measurements should be repeated. If the difference remains > 20 mmHg then subsequent blood pressures should be recorded from the arm with the higher reading.

It should of course be remember that there are pathological causes of unequal blood pressure readings from the arms, such as supravalvular aortic stenosis. It is therefore prudent to listen to the heart sounds if a difference exists and further investigation if a very large difference is noted.

NICE also recommend taking a second reading during the consultation, if the first reading is > 140/90 mmHg. The lower reading of the two should determine further management.

NICE suggest offering ABPM or HBPM to any patient with a blood pressure >= 140/90 mmHg.

If however the blood pressure is >= 180/110 mmHg:

immediate treatment should be considered
if there are signs of papilloedema or retinal haemorrhages NICE recommend same day assessment by a specialist
NICE also recommend referral if a phaeochromocytoma is suspected (labile or postural hypotension, headache, palpitations, pallor and diaphoresis)

Ambulatory blood pressure monitoring (ABPM)

at least 2 measurements per hour during the person's usual waking hours (for example, between 08:00 and 22:00)
use the average value of at least 14 measurements

If ABPM is not tolerated or declined HBPM should be offered.

Home blood pressure monitoring (HBPM)

for each BP recording, two consecutive measurements need to be taken, at least 1 minute apart and with the person seated
BP should be recorded twice daily, ideally in the morning and evening
BP should be recorded for at least 4 days, ideally for 7 days
discard the measurements taken on the first day and use the average value of all the remaining measurements

Interpreting the results

ABPM/HBPM >= 135/85 mmHg (i.e. stage 1 hypertension)

treat if < 80 years of age AND any of the following apply; target organ damage, established cardiovascular disease, renal disease, diabetes or a 10-year cardiovascular risk equivalent to 20% or greater

ABPM/HBPM >= 150/95 mmHg (i.e. stage 2 hypertension)

offer drug treatment regardless of age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what drugs have been shown to improve mortality in patients with chronic heart failure

A

A number of drugs have been shown to improve mortality in patients with chronic heart failure:

ACE inhibitors (SAVE, SOLVD, CONSENSUS)
spironolactone (RALES)
beta-blockers (CIBIS)
hydralazine with nitrates (VHEFT-1)

No long-term reduction in mortality has been demonstrated for loop diuretics such as furosemide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NICE issued updated guidelines on management of heart failure in 2010, key points include:

A

NICE issued updated guidelines on management in 2010, key points include:

first-line treatment for all patients is both an ACE-inhibitor and a beta-blocker
second-line treatment is now either an aldosterone antagonist, angiotensin II receptor blocker or a hydralazine in combination with a nitrate
if symptoms persist cardiac resynchronisation therapy or digoxin* should be considered
diuretics should be given for fluid overload
offer annual influenza vaccine
offer one-off** pneumococcal vaccine

*digoxin has also not been proven to reduce mortality in patients with heart failure. It may however improve symptoms due to its inotropic properties. Digoxin is strongly indicated if there is coexistent atrial fibrillation

**adults usually require just one dose but those with asplenia, splenic dysfunction or chronic kidney disease need a booster every 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Features of severe aortic stenosis

A

Features of severe aortic stenosis

    narrow pulse pressure
    slow rising pulse
    delayed ESM
    soft/absent S2
    S4
    thrill
    duration of murmur
    left ventricular hypertrophy or failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of aortic stenosis

A

Causes of aortic stenosis

degenerative calcification (most common cause in older patients > 65 years)
bicuspid aortic valve (most common cause in younger patients < 65 years)
William's syndrome (supravalvular aortic stenosis)
post-rheumatic disease
subvalvular: HOCM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of aortic stenosis

A

Management

if asymptomatic then observe the patient is general rule
if symptomatic then valve replacement
if asymptomatic but valvular gradient > 50 mmHg and with features such as left ventricular systolic dysfunction then consider surgery
balloon valvuloplasty is limited to patients with critical aortic stenosis who are not fit for valve replacement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The management of stable angina comprises lifestyle changes, medication, percutaneous coronary intervention and surgery. NICE produced guidelines in 2011 covering the management of stable angina - what are they?

A
all:
1 - aspirin
2 - statin
3 - GTN 
4 - beta blocker or CCB (rate limiting)

then
1 - max dose BB or CCB eg atenolol 100mg OD
2 - then CCB AND BB

if a patient is on monotherapy and cannot tolerate the addition of a calcium channel blocker or a beta-blocker then consider one of the following drugs: a long-acting nitrate, ivabradine, nicorandil or ranolazine

if a patient is taking both a beta-blocker and a calcium-channel blocker then only add a third drug whilst a patient is awaiting assessment for PCI or CABG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

problems with nitrate tolerance in anti anginal medication routines

A

Nitrate tolerance

many patients who take nitrates develop tolerance and experience reduced efficacy
the BNF advises that patients who develop tolerance should take the second dose of isosorbide mononitrate after 8 hours, rather than after 12 hours. This allows blood-nitrate levels to fall for 4 hours and maintains effectiveness
this effect is not seen in patients who take modified release isosorbide mononitrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

use of ivabradine in angina

A

Ivabradine

a new class of anti-anginal drug which works by reducing the heart rate
acts on the If ('funny') ion current which is highly expressed in the sinoatrial node, reducing cardiac pacemaker activity
adverse effects: visual effects, particular luminous phenomena, are common. Bradycardia, due to the mechanism of action, may also be seen
there is no evidence currently of superiority over existing treatments of stable angina
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

when are J waves seen on an ECG

A

J waves are seen in hypothermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

when are delta waves seen on an ECG

A

delta waves are associated with Wolff Parkinson White syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

when are U waves seen on an ECG

A

Hypokalaemia - U waves on ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ECG features of hypokalaemia

A
U waves
    small or absent T waves (occasionally inversion)
    prolong PR interval
    ST depression
    long QT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what happens to a person in ventricular fibrillation

A

if the patient is conscious ventricular fibrillation (VF) can be excluded - the nature of VF means that it is not compatible with a cardiac output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is Ventricular tachycardia

A

Ventricular tachycardia (VT) is broad-complex tachycardia originating from a ventricular ectopic focus. It has the potential to precipitate ventricular fibrillation and hence requires urgent treatment.

There are two main types of VT:

monomorphic VT: most commonly caused by myocardial infarction

polymorphic VT: A subtype of polymorphic VT is torsades de pointes which is precipitated by prolongation of the QT interval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Causes of a prolonged QT interval
Congenital Jervell-Lange-Nielsen syndrome (includes deafness and is due to an abnormal potassium channel) Romano-Ward syndrome (no deafness) Drugs ``` amiodarone, sotalol, class 1a antiarrhythmic drugs tricyclic antidepressants, fluoxetine chloroquine terfenadine erythromycin ``` Other ``` electrolyte: hypocalcaemia, hypokalaemia, hypomagnesaemia acute myocardial infarction myocarditis hypothermia subarachnoid haemorrhage ```
26
management of Ventricular tachycardia
If the patient has adverse signs (systolic BP < 90 mmHg, chest pain, heart failure or rate > 150 beats/min) then immediate cardioversion is indicated. In the absence of such signs antiarrhythmics may be used. If these fail, then electrical cardioversion may be needed with synchronised DC shocks Drug therapy amiodarone: ideally administered through a central line lidocaine: use with caution in severe left ventricular impairment procainamide Verapamil should NOT be used in VT If drug therapy fails: ``` electrophysiological study (EPS) implant able cardioverter-defibrillator (ICD) - this is particularly indicated in patients with significantly impaired LV function ```
27
The Royal College of Physicians and NICE published guidelines on the management of atrial fibrillation (AF) in 2006 -
Agents used to control rate in patients with atrial fibrillation beta-blockers calcium channel blockers digoxin (not considered first-line anymore as they are less effective at controlling the heart rate during exercise. However, they are the preferred choice if the patient has coexistent heart failure) Agents used to maintain sinus rhythm in patients with a history of atrial fibrillation sotalol amiodarone flecainide others (less commonly used in UK): disopyramide, dofetilide, procainamide, propafenone, quinidine The table below indicates some of the factors which may be considered when considering either a rate control or rhythm control strategy: Factors favouring rate control: Older than 65 years History of ischaemic heart disease Factors favouring rhythm control: ``` Younger than 65 years Symptomatic First presentation Lone AF or AF secondary to a corrected precipitant (e.g. Alcohol) Congestive heart failure ```
28
Management of hypertension
Lifestyle advice should not be forgotten and is frequently tested in exams: a low salt diet is recommended, aiming for less than 6g/day, ideally 3g/day. The average adult in the UK consumes around 8-12g/day of salt. A recent BMJ paper* showed that lowering salt intake can have a significant effect on blood pressure. For example, reducing salt intake by 6g/day can lower systolic blood pressure by 10mmHg caffeine intake should be reduced the other general bits of advice remain: stop smoking, drink less alcohol, eat a balanced diet rich in fruit and vegetables, exercise more, lose weight ABPM/HBPM >= 135/85 mmHg (i.e. stage 1 hypertension) treat if < 80 years of age AND any of the following apply; target organ damage, established cardiovascular disease, renal disease, diabetes or a 10-year cardiovascular risk equivalent to 20% or greater ABPM/HBPM >= 150/95 mmHg (i.e. stage 2 hypertension) offer drug treatment regardless of age For patients < 40 years consider specialist referral to exclude secondary causes. Step 1 treatment: patients < 55-years-old: ACE inhibitor (A) patients > 55-years-old or of Afro-Caribbean origin: calcium channel blocker Step 2 treatment: ACE inhibitor + calcium channel blocker (A + C) Step 3 treatment: add a thiazide diuretic (D, i.e. A + C + D) NICE now advocate using either chlorthalidone (12.5-25.0 mg once daily) or indapamide (1.5 mg modified-release once daily or 2.5 mg once daily) in preference to a conventional thiazide diuretic such as bendroflumethiazide NICE define a clinic BP >= 140/90 mmHg after step 3 treatment with optimal or best tolerated doses as resistant hypertension. They suggest step 4 treatment or seeking expert advice Step 4 treatment: consider further diuretic treatment if potassium < 4.5 mmol/l add spironolactone 25mg od if potassium > 4.5 mmol/l add higher-dose thiazide-like diuretic treatment if further diuretic therapy is not tolerated, or is contraindicated or ineffective, consider an alpha- or beta-blocker Patients who fail to respond to step 4 measures should be referred to a specialist. NICE recommend: If blood pressure remains uncontrolled with the optimal or maximum tolerated doses of four drugs, seek expert advice if it has not yet been obtained. New drugs Direct renin inhibitors e.g. Aliskiren (branded as Rasilez) by inhibiting renin blocks the conversion of angiotensinogen to angiotensin I no trials have looked at mortality data yet. Trials have only investigated fall in blood pressure. Initial trials suggest aliskiren reduces blood pressure to a similar extent as angiotensin converting enzyme (ACE) inhibitors or angiotensin-II receptor antagonists adverse effects were uncommon in trials although diarrhoea was occasionally seen only current role would seem to be in patients who are intolerant of more established antihypertensive drugs
29
Blood pressure targets
Clinic BP: Age < 80 years 140/90 mmHg Age > 80 years 150/90 mmHg ABPM / HBPM Age < 80 years 135/85 mmHg Age > 80 years 145/85 mmHg
30
what causes the heart sounds
The first heart sound (S1) is caused by closure of the mitral and tricuspid valves whilst the second heart sound (S2) is due to aortic and pulmonary valve closure
31
S1 normal and abnormal
S1 closure of mitral and tricuspid valves soft if long PR or mitral regurgitation loud in mitral stenosis
32
S2 normal and abnormal
S2 closure of aortic and pulmonary valves soft in aortic stenosis splitting during inspiration is normal
33
S3 normal and abnormal
S3 (third heart sound) caused by diastolic filling of the ventricle considered normal if < 30 years old (may persist in women up to 50 years old) heard in left ventricular failure (e.g. dilated cardiomyopathy), constrictive pericarditis (called a pericardial knock)
34
S4 normal and abnormal
S4 (fourth heart sound) may be heard in aortic stenosis, HOCM, hypertension caused by atrial contraction against a stiff ventricle in HOCM a double apical impulse may be felt as a result of a palpable S4
35
what is Supraventricular tachycardia
Whilst strictly speaking the term supraventricular tachycardia (SVT) refers to any tachycardia that is not ventricular in origin the term is generally used in the context of paroxysmal SVT. Episodes are characterised by the sudden onset of a narrow complex tachycardia, typically an atrioventricular nodal re-entry tachycardia (AVNRT). Other causes include atrioventricular re-entry tachycardias (AVRT) and junctional tachycardias.
36
Acute management of Supraventricular tachycardia
Acute management vagal manoeuvres: e.g. Valsalva manoeuvre (The Valsalva maneuver or Valsalva manoeuvre is performed by moderately forceful attempted exhalation against a closed airway, usually done by closing one's mouth, pinching one's nose shut while pressing out as if blowing up a balloon.) intravenous adenosine 6mg → 12mg → 12mg: contraindicated in asthmatics - verapamil is a preferable option electrical cardioversion
37
Prevention of episodes of SVT
Prevention of episodes beta-blockers radio-frequency ablation
38
NICE released guidelines on the management of STEMI in 2013
These guidelines reiterate the need to offer primary PCI to patients who present within 12 hours of onset of symptoms, if it can be delivered within 120 minutes of the time when fibrinolysis could have been given. A practical example may be a patient who presents with a STEMI to a small district general hospital (DGH) which does not have facilities for PCI. If they cannot be transferred to a larger hospital for PCI within 120 minutes then fibrinolysis should be given. If the patient's ECG taken 90 minutes after fibrinolysis failed to show resolution of the ST elevation then they would then require transfer for PCI. Management of STEMI The 2008 British Thoracic Society oxygen therapy guidelines have now been widely adopted and oxygen should only be given if the oxygen saturations are < 94% Sublingual glyceryl trinitrate and intravenous morphine + metoclopramide should be given to help relieve the symptoms. Aspirin 300mg should be given to all patients (unless contraindicated). Following these initial steps there is a large amount of variation in practice in terms of which other medications are given prior to PCI. A second antiplatelet is normally given, usually ticagrelor, clopidogrel or prasurgel (all are antagonists of the P2Y12 adenosine diphosphate receptor). Other treatments that may be given include bivalirudin (a direct thrombin inhibitor, usually given alongside aspirin + clopidogrel) and a form of heparin (either low-molecular weight or unfractionated). → cath lab for primary PCI
39
ECG of RBBB vs LBBB?
One of the most common ways to remember the difference between LBBB and RBBB is WiLLiaM MaRRoW in LBBB there is a 'W' in V1 and a 'M' in V6 in RBBB there is a 'M' in V1 and a 'W' in V6
40
Causes of RBBB
Causes of RBBB normal variant - more common with increasing age right ventricular hypertrophy chronically increased right ventricular pressure - e.g. cor pulmonale pulmonary embolism myocardial infarction atrial septal defect cardiomyopathy or myocarditis
41
normal Creatinine
55-120 umol/l
42
normal urea
2.0-7 mmol/l
43
Acute myocardial infarction (MI) ECG changes
Acute myocardial infarction (MI) hyperacute T waves are often the first sign of MI but often only persists for a few minutes ST elevation may then develop the T waves typically become inverted within the first 24 hours. The inversion of the T waves can last for days to months pathological Q waves develop after several hours to days. This change usually persists indefinitely
44
Definition of ST elevation* on ECG
new ST elevation at the J-point in two contiguous leads with the cut-off points: >=0.2 mV in men or >= 0.15 mV in women in leads V2-V3 and/or >= 0.1 mV in other leads
45
what is atrial flutter
Atrial flutter is a form of supraventricular tachycardia characterised by a succession of rapid atrial depolarisation waves.
46
ECG findings in atrial flutter
ECG findings 'sawtooth' appearance as the underlying atrial rate is often around 300/min the ventricular or heart rate is dependent on the degree of AV block. For example if there is 2:1 block the ventricular rate will be 150/min flutter waves may be visible following carotid sinus massage or adenosine
47
management of atrial flutter
Management is similar to that of atrial fibrillation although mediction may be less effective atrial flutter is more sensitive to cardioversion however so lower energy levels may be used radiofrequency ablation of the tricuspid valve isthmus is curative for most patients
48
correlation between ECG leads and coronary artery regions
Anteroseptal - V1-V4 - Left anterior descending Inferior - II, III, aVF - Right coronary Anterolateral - V4-6, I, aVL - Left anterior descending or left circumflex Lateral - I, aVL +/- V5-6 - Left circumflex Posterior - Tall R waves V1-2 - Usually left circumflex, also right coronary
49
Acute coronary syndrome: management of NSTEMI
NICE produced guidelines in 2013 on the Secondary prevention in primary and secondary care for patients following a myocardial infarction management of unstable angina and non-ST elevation myocardial infarction (NSTEMI). These superceded the 2010 guidelines which advocated a risk-based approach to management which determined whether drugs such as clopidogrel were given. All patients should receive aspirin 300mg nitrates or morphine to relieve chest pain if required advise not giving oxygen unless the patient is hypoxic. Antithrombin treatment. Fondaparinux should be offered to patients who are not at a high risk of bleeding and who are not having angiography within the next 24 hours. If angiography is likely within 24 hours or a patients creatinine is > 265 µmol/l unfractionated heparin should be given. Clopidogrel 300mg should be given to all patients and continued for 12 months. Intravenous glycoprotein IIb/IIIa receptor antagonists (eptifibatide or tirofiban) should be given to patients who have an intermediate or higher risk of adverse cardiovascular events (predicted 6-month mortality above 3.0%), and who are scheduled to undergo angiography within 96 hours of hospital admission. Coronary angiography should be considered within 96 hours of first admission to hospital to patients who have a predicted 6-month mortality above 3.0%. It should also be performed as soon as possible in patients who are clinically unstable.
50
MOA of aspirin when treating acute coronary syndrome
Antiplatelet - inhibits the production of thromboxane A2
51
MOA of clopidogrel when treating acute coronary syndrome
Antiplatelet - inhibits ADP binding to its platelet receptor
52
MOA of enoxaparin when treating acute coronary syndrome
Activates antithrombin III, which in turn potentiates the inhibition of coagulation factors Xa
53
MOA of fondaparinux when treating acute coronary syndrome
Activates antithrombin III, which in turn potentiates the inhibition of coagulation factors Xa
54
MOA of bivalirudin when treating acute coronary syndrome
Reversible direct thrombin inhibitor
55
DVLA rules on cardiovascular diseases - hypertension
hypertension - can drive unless treatment causes unacceptable side effects, no need to notify DVLA. If Group 2 Entitlement the disqualifies from driving if resting BP consistently 180 mmHg systolic or more and/or 100 mm Hg diastolic or more
56
DVLA rules on cardiovascular diseases - angioplasty (elective)
angioplasty (elective) - 1 week off driving
57
DVLA rules on cardiovascular diseases - CABG
CABG - 4 weeks off driving
58
DVLA rules on cardiovascular diseases - acute coronary syndrome
acute coronary syndrome- 4 weeks off driving, 1 week if successfully treated by angioplasty
59
DVLA rules on cardiovascular diseases - angina
angina - driving must cease if symptoms occur at rest/at the wheel
60
DVLA rules on cardiovascular diseases - pacemaker insertion
pacemaker insertion - 1 week off driving
61
DVLA rules on cardiovascular diseases - implanted cardioverter-defibrillator
implantable cardioverter-defibrillator: if implanted for sustained ventricular arrhythmia: cease driving for 6 months. If implanted prophylatically then cease driving for 1 month
62
DVLA rules on cardiovascular diseases - successful catheter ablation for an arrhythmia
successful catheter ablation for an arrhythmia- 2 days off driving
63
DVLA rules on cardiovascular diseases - aortic aneurysm of 6cm or more
aortic aneurysm of 6cm or more - notify DVLA. Licensing will be permitted subject to annual review. An aortic diameter of 6.5 cm or more disqualifies patients from driving
64
DVLA rules on cardiovascular diseases - heart transplant
heart transplant: DVLA do not need to be notified
65
The single most common cause of secondary hypertension.
It is thought that between 5-10% of patients diagnosed with hypertension have primary hyperaldosteronism, including Conn's syndrome. This makes it the single most common cause of secondary hypertension.
66
types of renal disease that can cause secondary hypertension
Renal disease accounts for a large percentage of the other cases of secondary hypertension. Conditions which may increase the blood pressure include: glomerulonephritis pyelonephritis adult polycystic kidney disease renal artery stenosis
67
Endocrine disorders (other than primary hyperaldosteronism) that may also result in increased blood pressure:
``` phaeochromocytoma Cushing's syndrome Liddle's syndrome congenital adrenal hyperplasia (11-beta hydroxylase deficiency) acromegaly ```
68
causes of secondary hypertension other than renal diseases, endocrine disorders or primary hyperaldosteronism
Other causes include: ``` NSAIDs pregnancy coarctation of the aorta the combined oral contraceptive pill steroids MAOI ```
69
features of pericarditis
Pericarditis is one of the differentials of any patient presenting with chest pain. Features chest pain: may be pleuritic. Is often relieved by sitting forwards other symptoms include non-productive cough, dyspnoea and flu-like symptoms pericardial rub tachypnoea tachycardia
70
causes of pericarditis
Causes viral infections (Coxsackie) tuberculosis uraemia (causes 'fibrinous' pericarditis) trauma post-myocardial infarction, Dressler's syndrome connective tissue disease hypothyroidism
71
ECG changes in pericarditis
ECG changes widespread 'saddle-shaped' ST elevation PR depression: most specific ECG marker for pericarditis A modest rise in troponin is also seen in around one-third of patients with acute pericarditis. The widespread nature of the accompanying ECG changes (across coronary territories) points away from an ischaemic cause though.
72
Features of severe aortic stenosis
Features of severe aortic stenosis ``` narrow pulse pressure slow rising pulse delayed ESM soft/absent S2 S4 thrill duration of murmur left ventricular hypertrophy or failure ```
73
Causes of aortic stenosis
Causes of aortic stenosis degenerative calcification (most common cause in older patients > 65 years) bicuspid aortic valve (most common cause in younger patients < 65 years) William's syndrome (supravalvular aortic stenosis) post-rheumatic disease subvalvular: HOCM
74
management of aortic stenosis
Management if asymptomatic then observe the patient is general rule if symptomatic then valve replacement if asymptomatic but valvular gradient > 50 mmHg and with features such as left ventricular systolic dysfunction then consider surgery balloon valvuloplasty is limited to patients with critical aortic stenosis who are not fit for valve replacement
75
what is torsades de pointes
Torsades de pointes ('twisting of the points') is a rare arrhythmia associated with a long QT interval. It may deteriorate into ventricular fibrillation and hence lead to sudden death
76
causes of a long QT interval
Causes of long QT interval congenital: Jervell-Lange-Nielsen syndrome, Romano-Ward syndrome antiarrhythmics: amiodarone, sotalol, class 1a antiarrhythmic drugs tricyclic antidepressants antipsychotics chloroquine terfenadine erythromycin electrolyte: hypocalcaemia, hypokalaemia, hypomagnesaemia myocarditis hypothermia subarachnoid haemorrhage
77
management of torsades de pointes
IV magnesium sulphate
78
what is HOCM
Hypertrophic obstructive cardiomyopathy (HOCM) is an autosomal dominant disorder of muscle tissue caused by defects in the genes encoding contractile proteins. The most common defects involve a mutation in the gene encoding β-myosin heavy chain protein or myosin binding protein C. The estimated prevalence is 1 in 500.
79
features of HOCM
Hypertrophic obstructive cardiomyopathy (HOCM) is an autosomal dominant disorder of muscle tissue caused by defects in the genes encoding contractile proteins. The most common defects involve a mutation in the gene encoding β-myosin heavy chain protein or myosin binding protein C. The estimated prevalence is 1 in 500. Features often asymptomatic dyspnoea, angina, syncope sudden death (most commonly due to ventricular arrhythmias), arrhythmias, heart failure jerky pulse, large 'a' waves, double apex beat ejection systolic murmur: increases with Valsalva manoeuvre and decreases on squatting Associations Friedreich's ataxia Wolff-Parkinson White Echo - mnemonic - MR SAM ASH mitral regurgitation (MR) systolic anterior motion (SAM) of the anterior mitral valve leaflet asymmetric hypertrophy (ASH) ``` ECG left ventricular hypertrophy progressive T wave inversion deep Q waves atrial fibrillation may occasionally be seen ```
80
ecg features of HOCM
ECG left ventricular hypertrophy progressive T wave inversion deep Q waves atrial fibrillation may occasionally be seen
81
how do you diagnose heart failure
NICE issued updated guidelines on diagnosis and management in 2010. The choice of investigation is determined by whether the patient has previously had a myocardial infarction or not. Previous myocardial infarction arrange echocardiogram within 2 weeks No previous myocardial infarction measure serum natriuretic peptides (BNP) if levels are 'high' arrange echocardiogram within 2 weeks if levels are 'raised' arrange echocardiogram within 6 weeks
82
what is BNP
B-type natriuretic peptide (BNP) is a hormone produced mainly by the left ventricular myocardium in response to strain. Very high levels are associated with a poor prognosis in heart failure
83
what counts as hihg for BNP in heart failure
Normal levels < 100 pg/ml (29 pmol/litre) Raised levels 100-400 pg/ml (29-116 pmol/litre) High levels > 400 pg/ml (116 pmol/litre)
84
factors that increase circulating BNP levels
``` Left ventricular hypertrophy Ischaemia Tachycardia Right ventricular overload Hypoxaemia (including pulmonary embolism) GFR < 60 ml/min Sepsis COPD Diabetes Age > 70 Liver cirrhosis ```
85
factors that decrease circulating BNP levels
``` Obesity Diuretics ACE inhibitors Beta-blockers Angiotensin 2 receptor blockers Aldosterone antagonists ```
86
in a STEMI, what should all patients be given in the absence of contraindications
In the absence of contraindications, all patients should be given aspirin clopidogrel: the two major studies (CLARITY and COMMIT) both confirmed benefit but used different loading doses (300mg and 75mg respectively) low molecular weight heparin
87
use of oxygen therapy in STEMI
NICE suggest the following in terms of oxygen therapy: do not routinely administer oxygen, but monitor oxygen saturation using pulse oximetry as soon as possible, ideally before hospital admission. Only offer supplemental oxygen to: people with oxygen saturation (SpO2) of less than 94% who are not at risk of hypercapnic respiratory failure, aiming for SpO2 of 94-98% people with chronic obstructive pulmonary disease who are at risk of hypercapnic respiratory failure, to achieve a target SpO2 of 88-92% until blood gas analysis is available.
88
when should thrombolysis be used in STEMI
Primary percutaneous coronary intervention (PCI) has emerged as the gold-standard treatment for STEMI but is not available in all centres. Thrombolysis should be performed in patients without access to primary PCI With regards to thrombolysis: tissue plasminogen activator (tPA) has been shown to offer clear mortality benefits over streptokinase tenecteplase is easier to administer and has been shown to have non-inferior efficacy to alteplase with a similar adverse effect profile An ECG should be performed 90 minutes following thrombolysis to assess whether there has been a greater than 50% resolution in the ST elevation if there has not been adequate resolution then rescue PCI is superior to repeat thrombolysis for patients successfully treated with thrombolysis PCI has been shown to be beneficial. The optimal timing of this is still under investigation
89
what does NICE recommend in terms of glycaemic control in patients with diabetes mellitus in acute coronary syndromes
Glycaemic control in patients with diabetes mellitus in 2011 NICE issued guidance on the management of hyperglycaemia in acute coronary syndromes it recommends using a dose-adjusted insulin infusion with regular monitoring of blood glucose levels to glucose below 11.0 mmol/l intensive insulin therapy (an intravenous infusion of insulin and glucose with or without potassium, sometimes referred to as 'DIGAMI') regimes are not recommended routinely
90
how do you treat atrial fibrillation
Onset < 48 hours If the atrial fibrillation (AF) is definitely of less than 48 hours onset patients should be heparinised. Patients who have risk factors for ischaemic stroke should be put on lifelong oral anticoagulation. Otherwise, patients may be cardioverted using either: electrical - 'DC cardioversion' pharmacology - amiodarone if structural heart disease, flecainide in those without structural heart disease Following electrical cardioversion if AF is confirmed as being less than 48 hours duration then further anticoagulation is unnecessary Onset > 48 hours If the patient has been in AF for more than 48 hours then anticoagulation should be given for at least 3 weeks prior to cardioversion. An alternative strategy is to perform a transoesophageal echo (TOE) to exclude a left atrial appendage (LAA) thrombus. If excluded patients may be heparinised and cardioverted immediately. If there is a high risk of cardioversion failure (e.g. Previous failure or AF recurrence) then it is recommend to have at least 4 weeks amiodarone or sotalol prior to electrical cardioversion Following electrical cardioversion patients should be anticoagulated for at least 4 weeks. After this time decisions about anticoagulation should be taken on an individual basis depending on the risk of recurrence
91
what is Patent ductus arteriosus
Overview acyanotic congenital heart defect connection between the pulmonary trunk and descending aorta more common in premature babies, born at high altitude or maternal rubella infection in the first trimester
92
features of a Patent ductus arteriosus
Features ``` left subclavicular thrill continuous 'machinery' murmur large volume, bounding, collapsing pulse wide pulse pressure heaving apex beat ```
93
management of a Patent ductus arteriosus
Management indomethacin closes the connection in the majority of cases if associated with another congenital heart defect amenable to surgery then prostaglandin E1 is useful to keep the duct open until after surgical repair
94
Immediate management of suspected acute coronary syndrome (ACS)
glyceryl trinitrate aspirin 300mg. NICE do not recommend giving other antiplatelet agents (i.e. Clopidogrel) outside of hospital do not routinely give oxygen, only give if sats < 94%* perform an ECG as soon as possible but do not delay transfer to hospital. A normal ECG does not exclude ACS
95
patient present with acute chest pain, when to refer if suspects ACS
Referral current chest pain or chest pain in the last 12 hours with an abnormal ECG: emergency admission chest pain 12-72 hours ago: refer to hospital the same-day for assessment chest pain > 72 hours ago: perform full assessment with ECG and troponin measurement before deciding upon further action
96
NICE define anginal pain as the following:
1. constricting discomfort in the front of the chest, neck, shoulders, jaw or arms 2. precipitated by physical exertion 3. relieved by rest or GTN in about 5 minutes patients with all 3 features have typical angina patients with 2 of the above features have atypical angina patients with 1 or none of the above features have non-anginal chest pain
97
diagnostic tests used in those with anginal pain based upon their percieved risk of coronary artery disease
first estimate the likelihood of CAD in order to choose the appropriate diagnostic test. The risk tables are not reproduced here but can be found online via NICE. If patients have typical anginal symptoms and a risk of CAD is greater than 90% then no further diagnostic testing is required. It should be noted that all men over the age of 70 years who have typical anginal symptoms fall into this category. For patients with an estimated risk of 10-90% the following investigations are recommended. Note the absence of the exercise tolerance test: 61-90% - Coronary angiography 30-60% - Functional imaging, for example: myocardial perfusion scan with SPECT stress echocardiography first-pass contrast-enhanced magnetic resonance (MR) perfusion MR imaging for stress-induced wall motion abnormalities. 10-29% CT calcium scoring the risk of a patient having coronary artery disease (CAD) is calculated based on their symptoms (whether they have typical angina, atypical angina or non-anginal chest pain), age, gender and risk factors. USE THE GRACE SCORING SYSTEM the table is called = Percentage of people estimated to have coronary artery disease according to typicality of symptoms, age, sex and risk factors. stratifies by description of pain e.g. typical atypical non-angina, then by gender then by age then by presence of risk factors to give a percentage risk.
98
what is pre-eclampsia
Pre-eclampsia is a condition seen after 20 weeks gestation characterised by pregnancy-induced hypertension in association with proteinuria (> 0.3g / 24 hours). Oedema used to be third element of the classic triad but is now often not included in the definition as it is not specific Pregnancy-induced hypertension in association with proteinuria (> 0.3g / 24 hours) Oedema may occur but is now less commonly used as a criteria Occurs in around 5% of pregnancies
99
Pre-eclampsia is important as it predisposes to the following problems
Pre-eclampsia is important as it predisposes to the following problems fetal: prematurity, intrauterine growth retardation eclampsia haemorrhage: placental abruption, intra-abdominal, intra-cerebral cardiac failure multi-organ failure
100
pre-eclampsia Risk factors
Risk factors ``` > 40 years old nulliparity (or new partner) multiple pregnancy body mass index > 30 kg/m^2 diabetes mellitus pregnancy interval of more than 10 years family history of pre-eclampsia previous history of pre-eclampsia pre-existing vascular disease such as hypertension or renal disease ```
101
Features of severe pre-eclampsia
Features of severe pre-eclampsia hypertension: typically > 170/110 mmHg and proteinuria as above proteinuria: dipstick ++/+++ headache visual disturbance papilloedema RUQ/epigastric pain hyperreflexia platelet count < 100 * 106/l, abnormal liver enzymes or HELLP syndrome
102
management of pre-eclampsia
Management consensus guidelines recommend treating blood pressure > 160/110 mmHg although many clinicians have a lower threshold oral labetalol is now first-line following the 2010 NICE guidelines. Nifedipine and hydralazine may also be used delivery of the baby is the most important and definitive management step. The timing depends on the individual clinical scenario
103
features of complete heart block
Features ``` syncope heart failure regular bradycardia (30-50 bpm) wide pulse pressure JVP: cannon waves in neck variable intensity of S1 ```
104
define First degree heart block
First degree heart block PR interval > 0.2 seconds
105
define Second degree heart block
Second degree heart block type 1 (Mobitz I, Wenckebach): progressive prolongation of the PR interval until a dropped beat occurs type 2 (Mobitz II): PR interval is constant but the P wave is often not followed by a QRS complex
106
define Third degree (complete) heart block
Third degree (complete) heart block there is no association between the P waves and QRS complexes
107
2 common tricyclic antidepressants that people overdose on and effects
Overdose of tricyclic antidepressants is a common presentation to emergency departments. Amitriptyline and dosulepin (dothiepin) are particularly dangerous in overdose. Early features relate to anticholinergic properties: dry mouth, dilated pupils, agitation, sinus tachycardia, blurred vision. ``` Features of severe poisoning include: arrhythmias seizures metabolic acidosis coma ``` ECG changes include: sinus tachycardia widening of QRS prolongation of QT interval Widening of QRS > 100ms is associated with an increased risk of seizures whilst QRS > 160ms is associated with ventricular arrhythmias
108
management of TCA overdose
Management IV bicarbonate may reduce the risk of seizures and arrhythmias in severe toxicity arrhythmias: class 1a (e.g. Quinidine) and class Ic antiarrhythmics (e.g. Flecainide) are contraindicated as they prolong depolarisation. Class III drugs such as amiodarone should also be avoided as they prolong the QT interval. Response to lignocaine is variable and it should be emphasized that correction of acidosis is the first line in management of tricyclic induced arrhythmias dialysis is ineffective in removing tricyclics
109
what might you see on an ECG when a paced heart rhythm is measured (imp to know so as not to confuse with pathology)
Pacing spikes can be seen before the widened QRS complex, most clearly in V3-V6. The widened QRS complex means that ventricles are paced rather than the atria. Ventricular pacing tends to be on the right side giving the left bundle branch block like waveform seen here.
110
indications for a permanent pacemaker
Pacemaker: permanent Indications for permanent pacemaker (PPM) insertion include: persistent symptomatic bradycardia e.g. sick sinus syndome complete heart block Mobitz type II AV block persistent AV block after myocardial infarction
111
whe can ACEI cause AKI
Patients with bilateral renovascular disease (e.g. renal artery stenosis) may develop an acute kidney injury (AKI) if ACE inhibitors are administered. This is because elevated angiotensin II levels constrict the efferent arteriole more than the afferent arteriole within the kidney, which normally helps to maintain glomerular capillary pressure and filtration. Removing this constriction by blocking angiotensin II formation can cause an abrupt fall in glomerular filtration rate.
112
4 possible side effects of ACEI
Side-effects: cough: occurs in around 15% of patients and may occur up to a year after starting treatment. Thought to be due to increased bradykinin levels angioedema: may occur up to a year after starting treatment hyperkalaemia first-dose hypotension: more common in patients taking diuretics also AKI
113
cautions and contraindications for ACEI
Cautions and contraindications pregnancy and breastfeeding - avoid renovascular disease - significant renal impairment may occur in patients who have undiagnosed bilateral renal artery stenosis aortic stenosis - may result in hypotension patients receiving high-dose diuretic therapy (more than 80 mg of furosemide a day) - significantly increases the risk of hypotension hereditary of idiopathic angioedema
114
what should you monuitor in someone being given ACEI
Monitoring urea and electrolytes should be checked before treatment is initiated and after increasing the dose a rise in the creatinine and potassium may be expected after starting ACE inhibitors. Acceptable changes are an increase in serum creatinine, up to 30%* from baseline and an increase in potassium up to 5.5 mmol/l*. *Renal Association UK, Clinical Knowledge Summaries quote 50% which seems rather high. SIGN advise that the fall in eGFR should be less than 20%. The NICE CKD guidelines suggest that a decrease in eGFR of up to 25% or a rise in creatinine of up to 30% is acceptable
115
give 3 ARBs
Examples candesartan losartan irbesartan Like ACE inhibitors they should be used with caution in patients with renovascular disease. Side-effects include hypotension and hyperkalaemia.
116
MOA of ARBs
Mechanism | block effects of angiotensin II at the AT1 receptor
117
evidence base for use of ARBs
Evidence base shown to reduce progression of renal disease in patients with diabetic nephropathy evidence base that losartan reduces CVA and IHD mortality in hypertensive patients
118
management of peri-arrest tqachycardias
The 2010 Resuscitation Council (UK) guidelines have simplified the advice given for the management of peri-arrest tachycardias. Separate algorithms for the management of broad-complex tachycardia, narrow complex tachycardia and atrial fibrillation have been replaced by one unified treatment algorithm Following basic ABC assessment, patients are classified as being stable or unstable according to the presence of any adverse signs: shock: hypotension (systolic blood pressure < 90 mmHg), pallor, sweating, cold, clammy extremities, confusion or impaired consciousness syncope myocardial ischaemia heart failure If any of the above adverse signs are present then synchronised DC shocks should be given Treatment following this is given according to whether the QRS complex is narrow or broad and whether the rhythm is regular or irregular.The full treatment algorithm can be found at the Resuscitation Council website, below is a very limited summary: Broad-complex tachycardia Regular assume ventricular tachycardia (unless previously confirmed SVT with bundle branch block) loading dose of amiodarone followed by 24 hour infusion Irregular 1. AF with bundle branch block - treat as for narrow complex tachycardia 2. Polymorphic VT (e.g. Torsade de pointes) - IV magnesium Narrow-complex tachycardia Regular vagal manoeuvres followed by IV adenosine if above unsuccessful consider diagnosis of atrial flutter and control rate (e.g. Beta-blockers) Irregular probable atrial fibrillation if onset < 48 hr consider electrical or chemical cardioversion rate control (e.g. Beta-blocker or digoxin) and anticoagulation
119
signs of shock
shock: hypotension (systolic blood pressure < 90 mmHg), pallor, sweating, cold, clammy extremities, confusion or impaired consciousness
120
most common symptom in PE
tachypnoea. Around 95% of patients with a PE have a respiratory rate > 16/min. Tachypnoea is not as common in any of the other diagnoses. A low-grade temperature is also an under appreciated sign of pulmonary embolism.
121
textbook triad for PE
We know from experience that few patients (around 10%) present with the medical student textbook triad of pleuritic chest pain, dyspnoea and haemoptysis. Pulmonary embolism can be difficult to diagnose as it can present with virtually any cardiorespiratory symptom/sign depending on it's location and size.
122
4 most common features in PE
The PIOPED study1 in 2007 looked at the frequency of different symptoms and signs in patients who were diagnosed with pulmonary embolism. The relative frequency of common clinical signs is shown below: Tachypnea (respiratory rate >16/min) - 96% Crackles - 58% Tachycardia (heart rate >100/min) - 44% Fever (temperature >37.8°C) - 43% It is interesting to note that the Well's criteria for diagnosing a PE use tachycardia rather than tachypnoea.
123
management of suspected PE
2012 NICE guidelines All patients with symptoms or signs suggestive of a PE should have a history taken, examination performed and a chest x-ray to exclude other pathology. If a PE is still suspected a two-level PE Wells score should be performed:
124
contents of a two level PE wells score
Clinical signs and symptoms of DVT (minimum of leg swelling and pain with palpation of the deep veins) 3 An alternative diagnosis is less likely than PE 3 Heart rate > 100 beats per minute 1.5 Immobilisation for more than 3 days or surgery in the previous 4 weeks 1.5 Previous DVT/PE 1.5 Haemoptysis 1 Malignancy (on treatment, treated in the last 6 months, or palliative) 1 Clinical probability simplified scores PE likely - more than 4 points PE unlikely - 4 points or less If a PE is 'likely' (more than 4 points) arrange an immediate computed tomography pulmonary angiogram (CTPA). If there is a delay in getting the CTPA then give low-molecular weight heparin until the scan is performed. If a PE is 'unlikely' (4 points or less) arranged a D-dimer test. If this is positive arrange an immediate computed tomography pulmonary angiogram (CTPA). If there is a delay in getting the CTPA then give low-molecular weight heparin until the scan is performed. If the patient has an allergy to contrast media or renal impairment a V/Q scan should be used instead of a CTPA.
125
suspected PE - CTPA or V/Q scan?
The consensus view from the British Thoracic Society and NICE guidelines is as follows: computed tomographic pulmonary angiography (CTPA) is now the recommended initial lung-imaging modality for non-massive PE. Advantages compared to V/Q scans include speed, easier to perform out-of-hours, a reduced need for further imaging and the possibility of providing an alternative diagnosis if PE is excluded if the CTPA is negative then patients do not need further investigations or treatment for PE ventilation-perfusion scanning may be used initially if appropriate facilities exist, the chest x-ray is normal, and there is no significant symptomatic concurrent cardiopulmonary disease
126
ECG changes in PE
ECG the classic ECG changes seen in PE are a large S wave in lead I, a large Q wave in lead III and an inverted T wave in lead III - 'S1Q3T3'. However this change is seen in no more than 20% of patients right bundle branch block and right axis deviation are also associated with PE sinus tachycardia may also be seen
127
most common valve replacements
The most common valves which need replacing are the aortic and mitral valve. There are two main options for replacement: biological (bioprosthetic) or mechanical.
128
disadv of biological valves and medication needed, who gets them
Usually bovine or porcine in origin Major disadvantage is structural deterioration and calcification over time. Most older patients ( > 65 years for aortic valves and > 70 years for mitral valves) receive a bioprosthetic valve Long-term anticoagulation not usually needed. Warfarin may be given for the first 3 months depending on patient factors. Low-dose aspirin is given long-term.
129
mechanical hert valves - which ones, adv, disadv, medication
The most common type now implanted is the bileaflet valve. Ball-and-cage valves are rarely used nowadays Mechanical valves have a low failure rate Major disadvantage is the increased risk of thrombosis meaning long-term anticoagulation is needed. Aspirin is normally given in addition unless there is a contraindication. Target INR aortic: 2.0-3.0 mitral: 2.5-3.5
130
features of aortic regurg
``` Features early diastolic murmur collapsing pulse wide pulse pressure mid-diastolic Austin-Flint murmur in severe AR - due to partial closure of the anterior mitral valve cusps caused by the regurgitation streams ```
131
causes of aortic regurg due to valvular disease
``` Causes (due to valve disease) rheumatic fever infective endocarditis connective tissue diseases e.g. RA/SLE bicuspid aortic valve ```
132
causes of aortic regurg due to aortic root disease
``` Causes (due to aortic root disease) aortic dissection spondylarthropathies (e.g. ankylosing spondylitis) hypertension syphilis Marfan's, Ehler-Danlos syndrome ```
133
what is Pulsus parodoxus
Pulsus parodoxus greater than the normal (10 mmHg) fall in systolic blood pressure during inspiration → faint or absent pulse in inspiration severe asthma, cardiac tamponade
134
cause of Slow-rising/plateau pulse
Slow-rising/plateau | aortic stenosis
135
cause of collapsing pulse
Collapsing aortic regurgitation patent ductus arteriosus hyperkinetic (anaemia, thyrotoxic, fever, exercise/pregnancy)
136
what is and what causes pulsus alternans
Pulsus alternans regular alternation of the force of the arterial pulse severe LVF eg hocm
137
what is bisferiens pulse and what causes it
Bisferiens pulse 'double pulse' - two systolic peaks mixed aortic valve disease or HOCM
138
caus eof jerky pulse
'Jerky' pulse | hypertrophic obstructive cardiomyopathy*
139
cause of the heart sounds s1 and s2
The first heart sound (S1) is caused by closure of the mitral and tricuspid valves whilst the second heart sound (S2) is due to aortic and pulmonary valve closure
140
cause of normal and abnormal S1
S1 closure of mitral and tricuspid valves soft if long PR or mitral regurgitation loud in mitral stenosis
141
cause of normal and abnormal S2
S2 closure of aortic and pulmonary valves soft in aortic stenosis splitting during inspiration is normal
142
cause of S3
S3 (third heart sound) caused by diastolic filling of the ventricle considered normal if < 30 years old (may persist in women up to 50 years old) heard in left ventricular failure (e.g. dilated cardiomyopathy), constrictive pericarditis (called a pericardial knock)
143
cause of S4
S4 (fourth heart sound) may be heard in aortic stenosis, HOCM, hypertension caused by atrial contraction against a stiff ventricle in HOCM a double apical impulse may be felt as a result of a palpable S4
144
what is gallop rhythm
Gallop rhythm (S3) is an early sign of LVF A gallop rhythm refers to a (usually abnormal) rhythm of the heart on auscultation.[1] It includes three or four sounds, thus resembling the sounds of a gallop. The normal heart rhythm contains two audible heart sounds called S1 and S2 that give the well-known "lub-dub" rhythm; they are caused by the closing of valves in the heart. A gallop rhythm contains another sound, called S3 or S4, dependent upon where in the cycle this added sound comes. Gallop rhythms may be heard in young or athletic people, but may also be a sign of serious cardiac problems like heart failure as well as pulmonary edema.
145
The following ECG changes may be seen in hypothermia
``` bradycardia 'J' wave - small hump at the end of the QRS complex first degree heart block long QT interval atrial and ventricular arrhythmias ```
146
problem with ACEI in aortic stenosis
Patients with aortic stenosis are at risk of profound hypotension with ACE inhibitors.
147
what classification is used to judge heart failure severity;
The New York Heart Association (NYHA) classification is widely used to classify the severity of heart failure: class 1, 2 , 3 and 4
148
NYHA Class I
The New York Heart Association (NYHA) classification is widely used to classify the severity of heart failure: NYHA Class I no symptoms no limitation: ordinary physical exercise does not cause undue fatigue, dyspnoea or palpitations
149
NYHA Class ii
The New York Heart Association (NYHA) classification is widely used to classify the severity of heart failure: NYHA Class II mild symptoms slight limitation of physical activity: comfortable at rest but ordinary activity results in fatigue, palpitations or dyspnoea
150
NYHA Class iii
The New York Heart Association (NYHA) classification is widely used to classify the severity of heart failure: NYHA Class III moderate symptoms marked limitation of physical activity: comfortable at rest but less than ordinary activity results in symptoms
151
NYHA Class iV
The New York Heart Association (NYHA) classification is widely used to classify the severity of heart failure: NYHA Class IV severe symptoms unable to carry out any physical activity without discomfort: symptoms of heart failure are present even at rest with increased discomfort with any physical activity
152
causes of Ejection systolic murmurs
Ejection systolic aortic stenosis pulmonary stenosis, HOCM ASD, Fallot's
153
causes of Holosystolic (pansystolic) murmurs
Holosystolic (pansystolic) mitral/tricuspid regurgitation (high-pitched and 'blowing' in character) VSD ('harsh' in character)
154
causes of late systolic murmurs
Late systolic mitral valve prolapse coarctation of aorta
155
causes of early diastolic murmurs
Early diastolic ``` aortic regurgitation (high-pitched and 'blowing' in character) Graham-Steel murmur (pulmonary regurgitation, again high-pitched and 'blowing' in character) ```
156
causes of mid-late diastolic murmurs
Mid-late diastolic ``` mitral stenosis ('rumbling' in character) Austin-Flint murmur (severe aortic regurgitation, again is 'rumbling' in character) ```
157
causes of continuous machine-like murmurs
Continuous machine-like mumur patent ductus arteriosus
158
features of cardiac tamponades
Features ``` dyspnoea raised JVP, with an absent Y descent - this is due to the limited right ventricular filling tachycardia hypotension muffled heart sounds pulsus paradoxus Kussmaul's sign (much debate about this) ECG: electrical alternans ```
159
Causes of ST depression
Causes of ST depression ``` secondary to abnormal QRS (LVH, LBBB, RBBB) ischaemia digoxin hypokalaemia syndrome X ```
160
ECG changes for thrombolysis or percutaneous intervention:
ECG changes for thrombolysis or percutaneous intervention: ST elevation of > 2mm (2 small squares) in 2 or more consecutive anterior leads (V1-V6) OR ST elevation of greater than 1mm (1 small square) in greater than 2 consecutive inferior leads (II, III, avF, avL) OR New Left bundle branch block
161
most common cause of death following an MI
Cardiac arrest This most commonly occurs due to patients developing ventricular fibrillation and is the most common cause of death following a MI. Patients are managed as per the ALS protocol with defibrillation.
162
Myocardial infarction: complications
``` 1- cardiac arrest 2 - cardiogenic shock 3 - chronic heart failure 4 - tachyarrhythmias 5 - bradyarrhythmias 6 - pericarditis 7 - ventricular aneurysm or free wall rupture 8 - ventricular septal defects 9 - acute mitral regurgitation ```
163
how common is pericarditis after an MI
Pericarditis in the first 48 hours following a transmural MI is common (c. 10% of patients). The pain is typical for pericarditis (worse on lying flat etc), a pericardial rub may be heard and a pericardial effusion may be demonstrated with an echocardiogram.
164
what is dressler's syndrome
Dressler's syndrome tends to occur around 2-6 weeks following a MI. The underlying pathophysiology is thought to be an autoimmune reaction against antigenic proteins formed as the myocardium recovers. It is characterised by a combination of fever, pleuritic pain, pericardial effusion and a raised ESR. It is treated with NSAIDs.
165
presentation of left ventricular aneurysm
Left ventricular aneurysm The ischaemic damage sustained may weaken the myocardium resulting in aneurysm formation. This is typically associated with persistent ST elevation and left ventricular failure. Thrombus may form within the aneurysm increasing the risk of stroke. Patients are therefore anticoagulated.
166
presentation of left ventricular free wall rupture
Left ventricular free wall rupture This is seen in around 3% of MIs and occurs around 1-2 weeks afterwards. Patients present with acute heart failure secondary to cardiac tamponade (raised JVP, pulsus paradoxus, diminished heart sounds). Urgent pericardiocentesis and thoracotomy are required.
167
what is Isolated systolic hypertension
Isolated systolic hypertension (ISH) is common in the elderly, affecting around 50% of people older than 70 years old. The Systolic Hypertension in the Elderly Program (SHEP) back in 1991 established that treating ISH reduced both strokes and ischaemic heart disease. Drugs such as thiazides were recommended as first line agents. This approach is contradicated by the 2011 NICE guidelines which recommends treating ISH in the same stepwise fashion as standard hypertension.
168
classificaiton of aortic dissection
Stanford classification type A - ascending aorta, 2/3 of cases type B - descending aorta, distal to left subclavian origin, 1/3 of cases DeBakey classification type I - originates in ascending aorta, propagates to at least the aortic arch and possibly beyond it distally type II - originates in and is confined to the ascending aorta type III - originates in descending aorta, rarely extends proximally but will extend distally
169
management of aortic dissection
Type A surgical management, but blood pressure should be controlled to a target systolic of 100-120 mmHg whilst awaiting intervention Type B* conservative management bed rest reduce blood pressure IV labetalol to prevent progression
170
what is Coarctation of the aorta
Coarctation of the aorta describes a congenital narrowing of the descending aorta. Overview more common in males (despite association with Turner's syndrome)
171
features of Coarctation of the aorta
Features infancy: heart failure adult: hypertension radio-femoral delay mid systolic murmur, maximal over back apical click from the aortic valve notching of the inferior border of the ribs (due to collateral vessels) is not seen in young children
172
Coarctation of the aorta is asociated with
Associations Turner's syndrome bicuspid aortic valve berry aneurysms neurofibromatosis
173
what is digoxin and how does it work
Digoxin is a cardiac glycoside now mainly used for rate control in the management of atrial fibrillation. As it has positive inotropic properties it is sometimes used for improving symptoms (but not mortality) in patients with heart failure. Mechanism of action decreases conduction through the atrioventricular node which slows the ventricular rate in atrial fibrillation and flutter increases the force of cardiac muscle contraction due to inhibition of the Na+/K+ ATPase pump. Also stimulates vagus nerve
174
features of digoxin toxicity
Digoxin toxicity Plasma concentration alone does not determine whether a patient has developed digoxin toxicity. The BNF advises that the likelihood of toxicity increases progressively from 1.5 to 3 mcg/l. Features generally unwell, lethargy, nausea & vomiting, anorexia, confusion, yellow-green vision arrhythmias (e.g. AV block, bradycardia)
175
precipitating factors of digoxin toxicity
Precipitating factors ``` classically: hypokalaemia* increasing age renal failure myocardial ischaemia hypomagnesaemia, hypercalcaemia, hypernatraemia, acidosis hypoalbuminaemia hypothermia hypothyroidism drugs: amiodarone, quinidine, verapamil, diltiazem, spironolactone (competes for secretion in distal convoluted tubule therefore reduce excretion), ciclosporin. Also drugs which cause hypokalaemia e.g. thiazides and loop diuretics ``` *hyperkalaemia may also worsen digoxin toxicity, although this is very small print
176
management of digoxin toxicity
Management Digibind correct arrhythmias monitor potassium
177
Dilated cardiomyopathy (DCM) basics
Dilated cardiomyopathy (DCM) basics dilated heart leading to systolic (+/- diastolic) dysfunction all 4 chambers affected but LV more so than RV features include arrhythmias, emboli, mitral regurgitation absence of congenital, valvular or ischaemic heart disease
178
causes of dilated cardiomyopathy
Causes often considered separate entities alcohol: may improve with thiamine postpartum hypertension Other causes inherited (see below) infections e.g. Coxsackie B, HIV, diphtheria, parasitic endocrine e.g. Hyperthyroidism infiltrative* e.g. Haemochromatosis, sarcoidosis neuromuscular e.g. Duchenne muscular dystrophy nutritional e.g. Kwashiorkor, pellagra, thiamine/selenium deficiency drugs e.g. Doxorubicin
179
Inherited dilated cardiomyopathy
Inherited dilated cardiomyopathy around a third of patients with DCM are thought to have a genetic predisposition a large number of heterogeneous defects have been identified the majority of defects are inherited in an autosomal dominant fashion although other patterns of inheritance are seen
180
features of pericarditis
Pericarditis Pericarditis is one of the differentials of any patient presenting with chest pain. Features chest pain: may be pleuritic. Is often relieved by sitting forwards other symptoms include non-productive cough, dyspnoea and flu-like symptoms pericardial rub tachypnoea tachycardia
181
causes of pericarditis
Causes viral infections (Coxsackie) tuberculosis uraemia (causes 'fibrinous' pericarditis) trauma post-myocardial infarction, Dressler's syndrome connective tissue disease hypothyroidism
182
ecg changes in pericarditis
ECG changes widespread 'saddle-shaped' ST elevation PR depression: most specific ECG marker for pericarditis
183
problems with short acting formulations of nifedipine
The BNF warns that short-acting formulations of nifedipine are associated with large variations in blood pressure and may cause reflex tachycardia
184
Beta-blocker overdose management
Management if bradycardic then atropine in resistant cases glucagon may be used
185
what is syncope
Syncope may be defined as a transient loss of consciousness due to global cerebral hypoperfusion with rapid onset, short duration and spontaneous complete recovery. Note how this definition excludes other causes of collapse such as epilepsy.
186
subclassifications of syncope
Reflex syncope (neurally mediated) vasovagal: triggered by emotion, pain or stress. Often referred to as 'fainting' situational: cough, micturition, gastrointestinal carotid sinus syncope Orthostatic syncope primary autonomic failure: Parkinson's disease, Lewy body dementia secondary autonomic failure: e.g. Diabetic neuropathy, amyloidosis, uraemia drug-induced: diuretics, alcohol, vasodilators volume depletion: haemorrhage, diarrhoea Cardiac syncope arrhythmias: bradycardias (sinus node dysfunction, AV conduction disorders) or tachycardias (supraventricular, ventricular) structural: valvular, myocardial infarction, hypertrophic obstructive cardiomyopathy others: pulmonary embolism Reflex syncope is the most common cause in all age groups although orthostatic and cardiac causes become progressively more common in older patients.
187
evaluation of syncope
Evaluation ``` cardiovascular examination postural blood pressure readings: a symptomatic fall in systolic BP > 20 mmHg or diastolic BP > 10 mmHg or decrease in systolic BP < 90 mmHg is considered diagnostic ECG carotid sinus massage tilt table test 24 hour ECG ```
188
normal ECG variants in an athlete
The following ECG changes are considered normal variants in an athlete: sinus bradycardia junctional rhythm first degree heart block Wenckebach phenomenon (progressive lengthening of conduction time in any cardiac tissue (most often the AV node or junction) with ultimate dropping of a beat (AV Wenckebach) or reversion to the initial conduction time (as in QRS Wenckebach))
189
Infective endocarditis diagnosed if | Infective endocarditis: Modified Duke criteria
Infective endocarditis diagnosed if pathological criteria positive, or 2 major criteria, or 1 major and 3 minor criteria, or 5 minor criteria Pathological criteria Positive histology or microbiology of pathological material obtained at autopsy or cardiac surgery (valve tissue, vegetations, embolic fragments or intracardiac abscess content) Major criteria Positive blood cultures two positive blood cultures showing typical organisms consistent with infective endocarditis, such as Streptococcus viridans and the HACEK group, or persistent bacteraemia from two blood cultures taken > 12 hours apart or three or more positive blood cultures where the pathogen is less specific such as Staph aureus and Staph epidermidis, or positive serology for Coxiella burnetii, Bartonella species or Chlamydia psittaci, or positive molecular assays for specific gene targets Evidence of endocardial involvement ``` positive echocardiogram (oscillating structures, abscess formation, new valvular regurgitation or dehiscence of prosthetic valves), or new valvular regurgitation ``` Minor criteria predisposing heart condition or intravenous drug use microbiological evidence does not meet major criteria fever > 38ºC vascular phenomena: major emboli, splenomegaly, clubbing, splinter haemorrhages, Janeway lesions, petechiae or purpura immunological phenomena: glomerulonephritis, Osler's nodes, Roth spots
190
use of cardiac Nuclear imaging
The ability to image the heart using non-invasive techniques such as MRI, CT and radionuclides has evolved rapidly over recent years. Nuclear imaging These techniques use radiotracers which are extracted by normal myocardium. Examples include: thallium technetium (99mTc) sestamibi: a coordination complex of the radioisotope technetium-99m with the ligand methoxyisobutyl isonitrile (MIBI), used in 'MIBI' or cardiac Single Photon Emission Computed Tomography (SPECT) scans fluorodeoxyglucose (FDG): used in Positron Emission Tomography (PET) scans The primary role of SPECT is to assess myocardial perfusion and myocardial viability. Two sets of images are usually acquired. First the myocardium at rest followed by images of the myocardium during stress (either exercise or following adenosine / dipyridamole). By comparing the rest with stress images any areas of ischaemia can classified as reversible or fixed (e.g. Following a myocardial infarction). Cardiac PET is predominately a research tool at the current time MUGA Multi Gated Acquisition Scan, also known as radionuclide angiography radionuclide (technetium-99m) is injected intravenously the patient is placed under a gamma camera may be performed as a stress test can accurately measure left ventricular ejection fraction. Typically used before and after cardiotoxic drugs are used
191
use of cardiac CT
Cardiac Computed Tomography (CT) Cardiac CT is useful for assessing suspected ischaemic heart disease, using two main methods: calcium score: there is known to be a correlation between the amount of atherosclerotic plaque calcium and the risk of future ischaemic events. Cardiac CT can quantify the amount of calcium producing a 'calcium score' contrast enhanced CT: allows visualisation of the coronary artery lumen If these two techniques are combined cardiac CT has a very high negative predictive value for ischaemic heart disease.
192
use of cardiac MRI
Cardiac MRI Cardiac MRI (commonly termed CMR) has become the gold standard for providing structural images of the heart. It is particularly useful when assessing congenital heart disease, determining right and left ventricular mass and differentiating forms of cardiomyopathy. Myocardial perfusion can also be assessed following the administration of gadolinium. Currently CMR provides limited data on the extent of coronary artery disease.
193
what is Phaeochromocytoma
Phaeochromocytoma is a rare catecholamine secreting tumour. About 10% are familial and may be associated with MEN type II, neurofibromatosis and von Hippel-Lindau syndrome Basics bilateral in 10% malignant in 10% extra-adrenal in 10% (most common site = organ of Zuckerkandl, adjacent to the bifurcation of the aorta)
194
features of a phaeochromocytoma
Features are typically episodic ``` hypertension (around 90% of cases, may be sustained) headaches palpitations sweating anxiety ```
195
tests to diagnose a phaeochromocytoma
Tests 24 hr urinary collection of metanephrines (sensitivity 97%*) this has replaced a 24 hr urinary collection of catecholamines (sensitivity 86%)
196
management of a phaeochromocytoma
Surgery is the definitive management. The patient must first however be stabilized with medical management: alpha-blocker (e.g. phenoxybenzamine), given before a beta-blocker (e.g. propranolol)
197
NICE produced guidelines on the management of patients following a myocardial infarction (MI) in 2013
All patients should be offered the following drugs: dual antiplatelet therapy (aspirin plus a second antiplatelet agent) ACE inhibitor beta-blocker statin Some selected lifestyle points: diet: advise a Mediterranean style diet, switch butter and cheese for plant oil based products. Do not recommend omega-3 supplements or eating oily fish exercise: advise 20-30 mins a day until patients are 'slightly breathless' sexual activity may resume 4 weeks after an uncomplicated MI. Reassure patients that sex does not increase their likelihood of a further MI. PDE5 inhibitors (e.g, sildenafil) may be used 6 months after a MI. They should however be avoided in patient prescribed either nitrates or nicorandil Clopidogrel since clopidogrel came off patent it is now much more widely used post-MI STEMI: the European Society of Cardiology recommend dual antiplatelets for 12 months. In the UK this means aspirin + clopidogrel non-ST segment elevation myocardial infarction (NSTEMI): following the NICE 2013 Secondary prevention in primary and secondary care for patients following a myocardial infarction guidelines clopidogrel should be given for the first 12 months Aldosterone antagonists patients who have had an acute MI and who have symptoms and/or signs of heart failure and left ventricular systolic dysfunction, treatment with an aldosterone antagonist licensed for post-MI treatment (e.g. eplerenone) should be initiated within 3-14 days of the MI, preferably after ACE inhibitor therapy
198
what is acute coronary syndrome
Acute coronary syndrome (ACS) refers to a group of conditions due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies.[1] The most common symptom is chest pain, often radiating to the left arm or angle of the jaw, pressure-like in character, and associated with nausea and sweating. Acute coronary syndrome usually occurs as a result of one of three problems: ST elevation myocardial infarction (30%), non ST elevation myocardial infarction (25%), or unstable angina (38%)
199
ecg changes in kyperkalaemia
ECG changes seen in hyperkalaemia include tall-tented T waves, small P waves, widened QRS leading to a sinusoidal pattern and asystole
200
causes of hyperkalaemia
Causes of hyperkalaemia: ``` acute renal failure drugs*: potassium sparing diuretics, ACE inhibitors, angiotensin 2 receptor blockers, spironolactone, ciclosporin, heparin** metabolic acidosis Addison's rhabdomyolysis massive blood transfusion ``` *beta-blockers interfere with potassium transport into cells and can potentially cause hyperkalaemia in renal failure patients - remember beta-agonists, e.g. Salbutamol, are sometimes used as emergency treatment **both unfractionated and low-molecular weight heparin can cause hyperkalaemia. This is thought to be caused by inhibition of aldosterone secretion
201
features of long QT
Features may be picked up on routine ECG or following family screening Long QT1 - usually associated with exertional syncope, often swimming Long QT2 - often associated with syncope occurring following emotional stress, exercise or auditory stimuli Long QT3 - events often occur at night or at rest sudden cardiac death
202
management of long QT
Management avoid drugs which prolong the QT interval and other precipitants if appropriate (e.g. Strenuous exercise) beta-blockers*** implantable cardioverter defibrillators in high risk cases
203
whats the most common mechanism by which drugs can cause long QT
*the usual mechanism by which drugs prolong the QT interval is blockage of potassium channels
204
how do you determine how well controlled someones diabetes is
HbA1c | NICE do not advocate increasing treatment unless the HbA1c is >= 6.5%.
205
infective endocarditis - prognostic factors
Poor prognostic factors Staph aureus infection (see below) prosthetic valve (especially 'early', acquired during surgery) culture negative endocarditis low complement levels Mortality according to organism staphylococci - 30% bowel organisms - 15% streptococci - 5%
206
Current antibiotic guidelines for infective endocarditis
Initial blind therapy: Native valve amoxicillin, consider adding low-dose gentamicin If penicillin allergic, MRSA or severe sepsis vancomycin + low-dose gentamicin If prosthetic valve vancomycin + rifampicin + low-dose gentamicin Native valve endocarditis caused by staphylococci: Flucloxacillin If penicillin allergic or MRSA vancomycin + rifampicin Prosthetic valve endocarditis caused by staphylococci: Flucloxacillin + rifampicin + low-dose gentamicin If penicillin allergic or MRSA vancomycin + rifampicin + low-dose gentamicin Endocarditis caused by fully-sensitive streptococci (e.g. viridans): Benzylpenicillin If penicillin allergic vancomycin + low-dose gentamicin Endocarditis caused by less sensitive streptococci: Benzylpenicillin + low-dose gentamicin If penicillin allergic vancomycin + low-dose gentamicin
207
infective endocarditis - indications for surgery
Indications for surgery severe valvular incompetence aortic abscess (often indicated by a lengthening PR interval) infections resistant to antibiotics/fungal infections cardiac failure refractory to standard medical treatment recurrent emboli after antibiotic therapy
208
diagnosis of bifascicular block
The ECG shows both right bundle branch block and left axis deviation indicating bifascicular block. Bifascicular block combination of RBBB with left anterior or posterior hemiblock e.g. RBBB with left axis deviation Trifascicular block features of bifascicular block as above + 1st degree heart block
209
diagnosis of rheumatic fever
Rheumatic fever develops following an immunological reaction to recent (2-6 weeks ago) Streptococcus pyogenes infection. Diagnosis is based on evidence of recent streptococcal infection accompanied by: 2 major criteria 1 major with 2 minor criteria Evidence of recent streptococcal infection ASOT > 200iu/mL history of scarlet fever positive throat swab increase in DNase B titre Major criteria ``` erythema marginatum Sydenham's chorea polyarthritis carditis (endo-, myo- or peri-) subcutaneous nodules ``` Minor criteria raised ESR or CRP pyrexia arthralgia (not if arthritis a major criteria) prolonged PR interval
210
what is long qt syndrome
Long QT syndrome (LQTS) is an inherited condition associated with delayed repolarization of the ventricles. It is important to recognise as it may lead to ventricular tachycardia and can therefore cause collapse/sudden death. The most common variants of LQTS (LQT1 & LQT2) are caused by defects in the alpha subunit of the slow delayed rectifier potassium channel. A normal corrected QT interval is less than 430 ms in males and 450 ms in females. An implantable cardioverter defibrillator is only required in high risk cases, for example if the patient has a QTc > 500ms or previous episodes of cardiac arrest.
211
what is Systemic inflammatory response syndrome (SIRS)
Systemic inflammatory response syndrome (SIRS) at least 2 of the following body temperature less than 36°C or greater than 38.3°C heart rate greater than 90/min respiratory rate greater than 20 breaths per minute blood glucose > 7.7mmol/L in the absence of known diabetes white cell count less than 4 or greater than 12 SIRS may occur as a result of an infection (bacterial, viral or fungal) or in response to a non-infective inflammatory cause, for example burns or pancreatitis. Sepsis is defined as SIRS in response to a proven or presumed infection. The mortality rate of sepsis is around 10%.
212
what is red flag' sepsis
Recently the Sepsis Trust have introduced the concept of 'red flag' sepsis. They recommend starting the 'sepsis six' if any 1 of the following are present: ``` Red flag signs: systolic blood pressure 40mmHg fall from baseline mean arterial pressure 131 per minute respiratory rate > 25 per minute* AVPU = V, P or U* ``` They also detail a number of laboratory findings which indicate severe sepsis. Severe sepsis sepsis with end organ dysfunction or hypoperfusion (indicated by hypotension, lactic acidosis or decreased urine output or others)
213
what is Septic shock
Septic shock severe sepsis with persistently low blood pressure which has failed to respond to the administration of intravenous fluids.
214
sepsis 6 management
Management Clearly the underlying cause of the patients sepsis needs to be identified and treated and the patient supported regardless of the cause or severity. If however any of the red flags are present the 'sepsis six' should be started straight away: 1. Administer high flow oxygen. 2. Take blood cultures 3. Give broad spectrum antibiotics 4. Give intravenous fluid challenges 5. Measure serum lactate and haemoglobin 6. Measure accurate hourly urine output
215
ECG of a posterior STEMI
ECG shows deep ST depression in leads V1-3 with tall T waves
216
if you decide to cardiovert someone in Atrial fibrillation what else should you consider
Onset 48 hours If the patient has been in AF for more than 48 hours then anticoagulation should be given for at least 3 weeks prior to cardioversion. An alternative strategy is to perform a transoesophageal echo (TOE) to exclude a left atrial appendage (LAA) thrombus. If excluded patients may be heparinised and cardioverted immediately. If there is a high risk of cardioversion failure (e.g. Previous failure or AF recurrence) then it is recommend to have at least 4 weeks amiodarone or sotalol prior to electrical cardioversion Following electrical cardioversion patients should be anticoagulated for at least 4 weeks. After this time decisions about anticoagulation should be taken on an individual basis depending on the risk of recurrence
217
Heart failure: acute management
``` Management options in acute heart failure include: oxygen diuretics opiates vasodilators inotropic agents CPAP ultrafiltration mechanical circulatory assistance: e.g. intra-aortic balloon counterpulsation or ventricular assist devices ``` Consideration should be given to discontinuing beta-blockers in the short-term. The patient is suffering from severe pulmonary oedema with bilateral course crackles and cough productive of white sputum. The patient has signs of right sided heart failure with raised JVP and peripheral oedema. They also have a history of MI and hypertension that are two risk factors for heart failure. NICE guidance on Acute Heart Failure 2014 states that a patient who has failed medical management of pulmonary oedema with severe dyspnoea should be considered for CPAP. BIPAP is not used in acute pulmonary oedema.
218
Pulsus parodoxus
greater than the normal (10 mmHg) fall in systolic blood pressure during inspiration → faint or absent pulse in inspiration severe asthma, cardiac tamponade
219
Slow-rising/plateau | pulse
aortic stenosis
220
Collapsing pulse
aortic regurgitation patent ductus arteriosus hyperkinetic (anaemia, thyrotoxic, fever, exercise/pregnancy)
221
Pulsus alternans
regular alternation of the force of the arterial pulse | severe LVF
222
Bisferiens pulse
'double pulse' - two systolic peaks mixed aortic valve disease or HOCM
223
'Jerky' pulse
hypertrophic obstructive cardiomyopathy* *HOCM may occasionally be associated with a bisferiens pulse
224
Adult advanced life support
The joint European Resuscitation Council and Resuscitation Council (UK) 2010 guidelines do not alter significantly from the 2005 guidelines. Please see the link for more details, below is only a very brief summary of key points / changes. Major points include: ratio of chest compressions to ventilation is 30:2 chest compressions are now continued while a defibrillator is charged during a VF/VT cardiac arrest, adrenaline 1 mg is given once chest compressions have restarted after the third shock and then every 3-5 minutes (during alternate cycles of CPR). In the 2005 guidelines, adrenaline was given just before the third shock. Amiodarone 300 mg is also given after the third shock atropine is no longer recommended for routine use in asystole or pulseless electrical activity (PEA). a single shock for VF/pulseless VT followed by 2 minutes of CPR, rather than a series of 3 shocks followed by 1 minute of CPR asystole/pulseless-electrical activity should be treated with 2 minutes of CPR, rather than 3, prior to reassessment of the rhythm delivery of drugs via a tracheal tube is no longer recommended following successful resuscitation oxygen should be titrated to achieve saturations of 94-98%. This is to address the potential harm caused by hyperoxaemia
225
Heart failure: non-drug management
Cardiac resynchronisation therapy: for patients with heart failure and wide QRS biventricular pacing improved symptoms and reduced hospitalisation in NYHA class III patients no reduction in mortality at present Exercise training: improves symptoms but not hospitalisation/mortality In symptomatic heart failure patients who are on optimal medical therapy, there are several treatment options to improve mortality. Cardiac resynchronisation therapy is indicated in patients with left ventricular dysfunction, ejection fracture 120ms. An Implantable cardiac defibrillator (ICD) is indicated in patients with previous sustained ventricular tachycardia, ejection fraction
226
causes of orthopnoea
LV failure or pleural effusion
227
relevance of hyponatraemia in heart failure
apparently its a marker of poor prognosis
228
does furosemide cause hyperglycaemia
no but it can push the blood glucose up a little bit.
229
name 3 drugs that cause ototoxicity
frusemide, vancomycin and gentamycin
230
relationship between hypo magnesia and hypokalaemia
Mg and K share a transporter and the body will preferentially uptake Mg so it is difficult to correct a hypokalaemia until a PT is Mg replete
231
vasoactive effect of morphine
it, along with other opiates i think, has a slight ventilatory effect
232
what is left ventricular ejection fraction
stroke volume/end diastolic volume ( i.e. the largest volume) normally about 60-65%
233
list some things that can cause dilated cardiomyopathy
``` chemotherapy haemochromatosis alcohol thyrotoxicosis viral infection ```
234
why do elderly people get AF easily
systemic issue e.g. infection causes stress response and this easily triggers AF in them. treat by correcting the underlying issue.
235
what drugs have best impact on prognosis in heart failure
1 - ACE inhibitors and ARBs, best. all of them 2 - beta blockers but only some - metoprolol, carvedilol and bisoprolol 3 - spironolactone digoxin only has symptomatic benefit
236
problems with ACEI
effectively a K sparing diuretic so can cause hyperkalamia can cause bad postural hypotension angioedema - lip swelling
237
lifestyle things that improve heart failure prognosis
weight loss stop smoking decrease salt intake water restriction is good for symptoms but doesn't affect prognosis
238
management of end stage heart failure
biventricular pacing cardiac transplant - v rare that eligible due to scarcity of hearts palliative care ultrafiltration - gets lots of volume off. intraaortic baloon pump is not a suitable option, its used occasionally to tide people over during flash pulmonary oedema but going out of fashion.
239
can someone have heart failure even if they have a normal ejection fraction?
yes. heart failure with preserved ejection fraction HFPEF. diastolic dysfunction occurs. BNP will be really high but echo might appear normal. use a cardiac MRI to get more info. need to aggressively control BP in these PTs they tolerate AF really badly as they have bad diastolic function anyway and AF removes the atrial contribution to diastolic filling so will decompensate suddenly.
240
effect of amyloidosis on the heart
can infiltrate the myocardium, restrict the movement of the ventricle wall and cause heart failure.
241
what is amyloidosis
Amyloidosis is a clinical disorder caused by extracellular and or intracellular deposition of insoluble abnormal amyloid fibrils that alter the normal function of tissues. Proteins that form amyloid fibrils differ in size, function, amino acid sequence and native structure but become insoluble aggregates that are similar in structure and in properties. really bad prognosis
242
how does paget's cause heart failure
the new bone is highly vascular and this causes a form of high output cardiac failure where the heart can't keep up
243
how do hydralazine and nitrates work in heart failure
hydralazine is an arterial dilator and nitrates are a veno-dilator.
244
lifestyle things that reduce hypertension
weight loss salt restriction reduce alcohol aerobic exercise. anything to reduce salt or long term vasomotor tone.
245
management of HTN in pregnancy
use methyldopa. SE = depression. all ACEI are teratogenic. They also made recommendations on reducing the risk of hypertensive disorders developing in the first place. Women who are at high risk of developing pre-eclampsia should take aspirin 75mg od from 12 weeks until the birth of the baby. High risk groups include: hypertensive disease during previous pregnancies chronic kidney disease autoimmune disorders such as SLE or antiphospholipid syndrome type 1 or 2 diabetes mellitus Hypertension in pregnancy in usually defined as: systolic > 140 mmHg or diastolic > 90 mmHg or an increase above booking readings of > 30 mmHg systolic or > 15 mmHg diastolic After establishing that the patient is hypertensive they should be categorised into one of the following groups 1 - preexisting hypertension 2 - Pregnancy-induced hypertension (PIH, also known as gestational hypertension) 3 - Pre-eclampsia
246
control of HTN crises late in pregnancy
labetalol hydralazine delivery
247
what is prinzmetal angina
due to coronary artery spasm. pain usually occurs during rest, ECG during this will show ST elevation, this resolves as pain does. PTs usually don't have the CVD risk factors. Mx - CCB +- long acting nitrates. in this instance aspirin and beta blockers can make it worse.
248
how should you investigate PTs with stable angina
1 - if known CAD and typical symptoms then none needed. if unstable angina then should admit to hospital. ``` then use a CAD likelihood chart to stratify likelihood of CAD. if 61-90% - angiography 30-60% - funcitonal imaging 10-29% CT less - reconsider diagnosis. ```
249
the effects of cocaine and its management
Cocaine is an alkaloid derived from the coca plant. It is widely used as a recreational stimulant. The price of cocaine has fallen sharply in the past decade resulting in cocaine toxicity becoming a much more frequent clinical problem. This increase has made cocaine a favourite topic of question writers. Mechanism of action cocaine blocks the uptake of dopamine, noradrenaline and serotonin The use of cocaine is associated with a wide variety of adverse effects: ``` Cardiovascular effects myocardial infarction both tachycardia and bradycardia may occur hypertension QRS widening and QT prolongation aortic dissection ``` ``` Neurological effects seizures mydriasis hypertonia hyperreflexia ``` Psychiatric effects agitation psychosis hallucinations Others hyperthermia metabolic acidosis rhabdomyolysis Management of cocaine toxicity in general benzodiazipines are generally first-line for most cocaine related problems chest pain: benzodiazipines + glyceryl trinitrate. If myocardial infarction develops then primary percutaneous coronary intervention hypertension: benzodiazipines + sodium nitroprusside the use of beta-blockers in cocaine-induced cardiovascular problems is a controversial issue. The American Heart Association issued a statement in 2008 warning against the use of beta-blockers (due to the risk of unopposed alpha-mediated coronary vasospasm) but many cardiologists since have questioned whether this is valid. If a reasonable alternative is given in an exam it is probably wise to choose it
250
Statins - who should get one, adverse effects,
Statins inhibit the action of HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis Adverse effects myopathy: includes myalgia, myositis, rhabdomyolysis and asymptomatic raised creatine kinase. Risks factors for myopathy include advanced age, female sex, low body mass index and presence of multisystem disease such as diabetes mellitus. Myopathy is more common in lipophilic statins (simvastatin, atorvastatin) than relatively hydrophilic statins (rosuvastatin, pravastatin, fluvastatin) liver impairment: the 2014 NICE guidelines recommend checking LFTs at baseline, 3 months and 12 months. Treatment should be discontinued if serum transaminase concentrations rise to and persist at 3 times the upper limit of the reference range there is some evidence that statins may increase the risk of intracerebral haemorrhage in patients who've previously had a stroke. This effect is not seen in primary prevention. For this reason the Royal College of Physicians recommend avoiding statins in patients with a history of intracerebral haemorrhage Who should receive a statin? all people with established cardiovascular disease (stroke, TIA, ischaemic heart disease, peripheral arterial disease) following the 2014 update, NICE recommend anyone with a 10-year cardiovascular risk >= 10% patients with type 2 diabetes mellitus should now be assessed using QRISK2 like other patients are, to determine whether they should be started on statins Statins should be taken at night as this is when the majority of cholesterol synthesis takes place. This is especially true for simvastatin which has a shorter half-life than other statins Current guidelines for lipid lowering* ``` Total cholesterol (mmol/l) LDL cholesterol Joint British Societies ```
251
Splitting of the second heart sound
In children and young adults the 2nd heart sound splits into two components during inspiration (lub da-dup) and comes together again in expiration. This is the result of minor changes in the stroke volume of L and R ventricles in respiration. Splitting of the second heart sound in expiration indicates an abnormality. During inspiration, venous return to the R side of the heart is increased, so R ventricular stroke volume is increased and closure of the pulmonary valve is delayed. At the same time, pooling of blood in the pulmonary veins reduces filling of the L ventricle and makes aortic valve closure slightly earlier than in expiration. The split may be widened by other factors that delay ventricular contraction, such as RBBB or pulmonary valve stenosis. 52 Conversely, anything that delays L ventricular contraction, such as LBBB or hypertrophic obstructive cardiomyopathy may so delay the aortic component of the 2nd heart sound that the normal relationship is reversed an there is increased splitting of the 2nd heart sound on expiration, with the sounds coming together on inspiration. Finally, in an atrial septal defect, there is a characteristically fixed splitting of the 2nd heart sound because the hole in the intra-atrial septum means that the L and R atrial pressure remains equal throughout the respiratory cycle
252
Third and fourth heart sounds
These are abnormal heart sounds that are heard in addition to the normal ones. The 3rd heart sound is a low-pitched, thudding sound that occurs in diastole and coincides with the end of the rapid phase of ventricular filling. 2 causes: Physiological – in young fit adults under circumstances of increased cardiac output (athletes/pregnancy). No pathological significance. Pathological – severe impairment of the L ventricle, eg. in dilated cardiac myopathy, after an MI, in massive PE. Patients with the pathological 3rd heart sound almost always have a tachycardia and the 1st and 2nd sounds are relatively quiet – ie. “da-da-boom, da-da-boom”. This called gallop rhythm. A 4th heart sound is an extra beat sound that coincides with atrial contraction. It is usually best heard in patients whose L atrium is hypertrophied but is NOT heard in mitral stenosis. A fourth sound sounds like “da-lub-dup, da-lub-dup”.
253
Ejection click
Ejection click This is a high-pitched ringing sound that usually follows very shortly after the 1st heart sound. It is a feature of aortic or pulmonary valve stenosis – it’s probably caused by the sudden opening of the deformed valve.
254
Opening snap
Opening snap This is a diastolic sound heard in mitral stenosis and associated with the tensing of the diaphragm formed by the stenosed valve. It is best heard to the L of the sternum and sounds a bit like the 2nd part of a widely split 2nd heart sound.
255
Sounds from artificial heart valves
An artificial heart valve usually makes a noise both on opening and closing. The closing sound is usually louder than the opening sound, so an aortic prosthesis will have a soft opening click just after the 1st heart sound and a loud closing click that contributes to the 2nd heart sound. Conversely, a mitral valve will give a soft opening click in a similar position to the opening snap of mitral stenosis and a loud closing click that contributes to the first heart sound.
256
Systolic murmurs
Systolic murmurs 3 causes: Leakage of blood through a structure that is usually closed during systole (mitral or tricuspid valves or the interventricular septum) Blood flow through a valve normally open in systole that has become abnormally narrowed (aortic or pulmonary stenosis) Increased blood flow through a normal valve (a flow murmur) Murmurs due to leakage of blood through an incompetent mitral or tricuspid valve or interventricular septum defect are usually of similar intensity throughout systole. They are called pansystolic murmurs. In mitral prolapse (where the valve is okay at the start of systole but then becomes incompetent) you get a mid or late systolic murmur. Murmurs that are due to blood being forced through a narrow aortic or pulmonary valve or to increased blood flow through a normal aortic or pulmonary valve tend to start quietly at the beginning of systole, rise to a crescendo in midsystole and then become quiet again. These are ejection systolic murmurs.
257
Diastolic murmurs
These can be divided into: Early diastolic murmurs – incompetence of the aortic or pulmonary valve. Maximal at beginning of diastole when aortic/pulmonary pressure is highest, and rapidly becomes quieter as pressure in the great vessel falls. It is described as a whispered letter ‘r’. Mid-diastolic murmurs – usually caused by blood flow through a narrowed mitral or tricuspid valve, or to increased flow through one of these (eg. children with atrial septal defect).
258
Innocent murmurs
These are murmurs that are not associated with any structural abnormality or with haemodynamic disturbance. They are common in children and young adults. They are: always systolic, always quiet, usually best heard at the L sternal edge, not associated with ventricular hypertrophy.
259
*Mid-systolic murmur
Aortic stenosis Pulmonary stenosis Atrial septal defect L and R outflow tract obstruction
260
*Pansystolic murmur
Mitral regurgitation Tricuspid regurgitation Ventricular septal defect
261
*Ejection-systolic murmur
``` Innocent murmur Aortic stenosis Pulmonary stenosis Hypertrophic cardiomyopathy Flow murmurs (fever, athlete’s heart) ```
262
*Mid-diastolic murmur
Mitral stenosis | Tricuspid stenosis
263
*Early-diastolic murmur
Aortic regurgitation | Pulmonary regurgitation
264
*Combined systolic and diastolic murmur
Patent ductus arteriosus | Aortic stenosis and regurgitation
265
Apex beat: abnormalities found on palpation, causes of impalpable
``` HILT: Heaving Impalpable Laterally displaced Thrusting/ Tapping ``` DOPES: Dextrocardia Obesity Pericarditis/ Pericardial tamponade/ Pneumothorax Emphysema Sinus inversus/ Student incompetence/ Scoliosis/ Skeletal abnormalities (eg pectus excavatum)
266
Atrial fibrillation: causes
``` PIRATES: Pulmonary: PE, COPD Iatrogenic Rheumatic heart: mirtral regurgitation Atherosclerotic: MI, CAD Thyroid: hyperthyroid Endocarditis Sick sinus syndrome ```
267
MI: signs and symptoms
``` PULSE: Persistent chest pains Upset stomach Lightheadedness Shortness of breath Excessive sweating ```
268
MI: therapeutic treatment
``` MONAH: Morphine Oxygen Nitrogen Aspirin Heparin ```
269
Murmurs: louder with inspiration vs expiration
"RILE": Right sided heart murmurs are louder on Inspiration. Left sided heart murmurs are loudest on Expiration.
270
Pericarditis: causes
``` CARDIAC RIND: Collagen vascular disease Aortic aneurysm Radiation Drugs (such as hydralazine) Infections Acute renal failure Cardiac infarction Rheumatic fever Injury Neoplasms Dressler's syndrome ```
271
JVP: raised JVP differential
PQRST (EKG waves): Pericardial effusion Quantity of fluid raised (fluid over load) Right heart failure Superior vena caval obstruction Tricuspid stenosis/ Tricuspid regurgitation/ Tamponade (cardiac)
272
Syncope causes, by system
``` HEAD HEART VESSELS: CNS causes include HEAD: Hypoxia/ Hypoglycemia Epilepsy Anxiety Dysfunctional brain stem (basivertebral TIA) ``` ``` Cardiac causes are HEART: Heart attack Embolism (PE) Aortic obstruction (IHSS, AS or myxoma) Rhythm disturbance, ventricular Tachycardia ``` ``` Vascular causes are VESSELS: Vasovagal Ectopic (reminds one of hypovolemia) Situational Subclavian steal ENT (glossopharyngeal neuralgia) Low systemic vascular resistance (Addison's, diabetic vascular neuropathy) Sensitive carotid sinus ```
273
Hypertension: secondary hypertension causes
``` CHAPS: Cushing's syndrome Hyperaldosteronism [aka Conn's syndrome] Aorta coarctation Phaeochromocytoma Stenosis of renal arteries Note: only 5% of hypertension cases are secondary, rest are primary ```
274
Heart failure causes
``` "HEART MAy DIE": Hypertension Embolism Anemia Rheumatic heart disease Thyrotoxicosis (incl. pregnancy) Myocardial infarct Arrythmia Y Diet & lifestyle Infection Endocarditis ```
275
which tachyarrhythmias are classified as SVTs
atrial tachy, AVN reentry tachy, AV reentry tachy. cf atrial fib and sinus tachy which are narrow complex but not counted as SVT.
276
which tachyarrhythmias can be stopped by carotid sinus massage, valsalva manoeuvres or adenosine?
these manœuvres transiently block the AVN so if the arrhythmia is dependent on it then they can reset the rhythm to normal sinus rhythm. Patients with AVNRT or AVRT may be able to terminate palpitations with vagal manoeuvres such as the Valsalva manoeuvre, breath holding, or coughing. AVNRT are more common and are due to having 2 distinct pathways in the region of the AVN, a fast one and a slow one. in AVRT there is an accessory pathway that bypasses the AVN, the most common type is WPW. Some patients can identify triggers such as caffeine or alcohol intake, which can initiate re-entrant tachycardia by increasing the frequency of extrasystoles. Sudden onset and offset of palpitations is typical for a re-entrant arrhythmia, while for sinus tachycardia onset and offset is usually gradual.
277
presentation of endocarditis
unlikely to affect a healthy individual if they don't have risk factors such as IVDU or dental surgery or replacement valves. v unwell, normal ECG, new heart murmur. cf pericarditis which can easily affect a previously healthy individual who just had a PMH of a mild infection . central chest pain, radiates to the back, makes them sit up and forwards to relieve. egg should support.
278
what type of MI can make you bradycardic
most commonly an inferior MI as in 60% of cases the RCA supplies the SAN. the LCA supplying it in the other 40%.
279
right coronary artery anatomy
supplies right ventricle and 25% of the blood to the LV. AVN in 90%, SAN in 60%, posterior DA in 85% which supplies the inferior wall, ventricular septum and posteromedial papillary muscle.
280
left coronary artery anatomy
main stem then LAD and L circumflex a. LAD = 2 thirds of the interventricualr septum, anterior part of the LV and apex. left marginal supplies left atrium, obtuse margin of the heart, posterior LV wall.
281
Mx a broad complex tachycardia.
1 - cv uncompromised 2 - cv compromised 1 - amiodarone 300mg loading, then 900mg over 24hrs. 2 - eg chest pain, heart failure signs, systolic under 90, reduced consciousness - synchronised cardioversion.
282
how does mitral stenosis cause a hoarse voice
causes LA enlargement, which via compression makes it difficult to clear bronchial secretions and compresses the recurrent laryngeal nerve .
283
leading cause of sudden death in young adults
HOCM. causes SIB, harsh ejection systolic murmur and double apex beat. and jerky pulse. can present with syncope or simply sudden death. half of cases have no family Hx and are usually due to sporadic mutations in the gene producing the beta-myosin heavy chain.
284
what is an anacrotic pulse
another term for a slow rising pulse as seen in aortic stenosis.
285
causes of a bounding pulse
co2 liver failure sepsis narcosis.
286
dd of irregularly irregular pulse
atiral fib or regular pulse with multiple ectopics. do an ECG.
287
whats a thready pulse
a barely palpable one as found in shock.
288
what are the different descriptions of a liver edge
smooth, craggy (cloud), and nodular. | hard (bone), firm (cartilage), soft (muscle).
289
what actually happens in an MI
endothelial damage and rupture or fissuring of a plaque causes platelet aggregation and thrombus formation. vasospasm is induced by local inflam mediators causing further reduction in blood supply.
290
what does a posterior MI look like and what vessel is affected
tall R waves and st segment depression in V1-3 and V6. caused by blockage in the left circumflex coronary artery.
291
in an upper Gi bleed, when are high dose PPI indicated
after endoscopy if it diagnoses a peptide ulcer rather than say varices.
292
is a raised troponin diagnostic for a MI?
no. can also occur in myocarditis, pericarditis, PE, sepsis, renal failure.
293
what is brittle asthma
2 types type 1 - wide PEF variability during the day despite intense therapy type 2 - sudden severe attacks on a background of apparently well controlled asthma
294
suggested anticoagulation strategy based on CHADS VASc score:
Score Anticoagulation 0 = No treatment 1 = Males: Consider anticoagulation Females: No treatment 2 or more = Offer anticoagulation Doctors have always thought carefully about the risk/benefit profile of starting someone on warfarin. A history of falls, old age, alcohol excess and a history of previous bleeding are common things that make us consider whether warfarinisation is in the best interests of the patient. NICE now recommend we formalise this risk assessment using the HASBLED scoring system.
295
Doctors have always thought carefully about the risk/benefit profile of starting someone on warfarin. A history of falls, old age, alcohol excess and a history of previous bleeding are common things that make us consider whether warfarinisation is in the best interests of the patient. NICE now recommend we formalise this risk assessment using the HASBLED scoring system. what are the criteria
H - Hypertension, uncontrolled, systolic BP > 160 mmHg = 1point A - Abnormal renal function (dialysis or creatinine > 200) = 1 point for any renal abnormalities Or Abnormal liver function (cirrhosis, bilirubin > 2 times normal, ALT/AST/ALP > 3 times normal = 1 point for any liver abnormalities S Stroke, history of =1 B Bleeding, history of bleeding or tendency to bleed =1 L Labile INRs (unstable/high INRs, time in therapeutic range 65 years) = 1 D Drugs Predisposing to Bleeding (Antiplatelet agents, NSAIDs) = 1 for drugs Or Alcohol Use (>8 drinks/week) = 1 for alcohol
296
Sildenafil CI and SE
Sildenafil is a phosphodiesterase type V inhibitor used in the treatment of impotence. Contraindications patients taking nitrates and related drugs such as nicorandil hypotension recent stroke or myocardial infarction (NICE recommend waiting 6 months) non-arteritic anterior ischaemic optic neuropathy ``` Side-effects visual disturbances e.g. blue discolouration, non-arteritic anterior ischaemic neuropathy nasal congestion flushing gastrointestinal side-effects headache ```
297
Myocardial infarction: secondary prevention
NICE produced guidelines on the management of patients following a myocardial infarction (MI) in 2013. Some key points are listed below All patients should be offered the following drugs: dual antiplatelet therapy (aspirin plus a second antiplatelet agent) ACE inhibitor beta-blocker statin Some selected lifestyle points: diet: advise a Mediterranean style diet, switch butter and cheese for plant oil based products. Do not recommend omega-3 supplements or eating oily fish exercise: advise 20-30 mins a day until patients are 'slightly breathless' sexual activity may resume 4 weeks after an uncomplicated MI. Reassure patients that sex does not increase their likelihood of a further MI. PDE5 inhibitors (e.g, sildenafil) may be used 6 months after a MI. They should however be avoided in patient prescribed either nitrates or nicorandil Clopidogrel since clopidogrel came off patent it is now much more widely used post-MI STEMI: the European Society of Cardiology recommend dual antiplatelets for 12 months. In the UK this means aspirin + clopidogrel non-ST segment elevation myocardial infarction (NSTEMI): following the NICE 2013 Secondary prevention in primary and secondary care for patients following a myocardial infarction guidelines clopidogrel should be given for the first 12 months Aldosterone antagonists patients who have had an acute MI and who have symptoms and/or signs of heart failure and left ventricular systolic dysfunction, treatment with an aldosterone antagonist licensed for post-MI treatment (e.g. eplerenone) should be initiated within 3-14 days of the MI, preferably after ACE inhibitor therapy
298
what is electrical alternans
Electrical alternans is an electrocardiographic phenomenon of alternation of QRS complex amplitude or axis between beats and a possible wandering base-line. It is seen in cardiac tamponade and severe pericardial effusion and is thought to be related to changes in the ventricular electrical axis due to fluid in the pericardium, as the heart essentially wobbles in the fluid filled pericardial sac.[1] Generally electrical alternans can be seen with tamponade, and narrow AV junctional reenterant tachycardia with an accessory pathway (such as WPW syndrome). A similar phenomenon, pseudo-alternans, can be seen in bigeminal PVC in the PR interval, alternans pre-excitation, and alternans bundle branch block.[1] For the most part however, the most serious condition to rule out is tamponade. Electrical alternans with sinus tachycardia is a highly specific sign for large pericardial effusion. This is due to the swinging motion of the heart in the pericardial cavity causing a beat-to-beat variation in QRS axis and amplitude. Patients with cardiac tamponade and hemodynamic compromise should have emergency pericardiocentesis.
299
heart failure management algorithm
1 - diagnose heart failure due to left ventricular systolic dysfunction 2 - ACEI and beta blocker. ARB as alternative to ACEI 3 - specialist review 4 - if still symptomatic consider: aldosterone antagonist, ARB, hydralazine and nitrate esp if afrocarribean. 5 - if symptoms STILL persist - digoxin, cardiac resynchronisation therapy. on the side- (offer rehab, education and diuretics for fluid symptoms. )
300
what is gestational hypertension
Pregnancy-induced hypertension (PIH, also known as gestational hypertension) Hypertension (as defined above) occurring in the second half of pregnancy (i.e. after 20 weeks) No proteinuria, no oedema Occurs in around 5-7% of pregnancies Resolves following birth (typically after one month). Women with PIH are at increased risk of future pre-eclampsia or hypertension later in life
301
cocaine induced stemi Rx
MONA be liberal with benzos, more so than other MI DO NOT use beta blockers or you get unopposed alpha action which will worsen.
302
pericarditis Rx
NSAIDS or colchicine if NSAIDS are CI
303
which narrow complex tachycardia is irregular
atrial fibrillation. all the others are regular e.g. AVRT, AVNRT, atrial flutter, sinus tacky.
304
difference between orthodromic and antidromic AVRT
orthodromic is narrow complex, antidromic is broad.
305
how do you get someone to do the valsalva
put a syringe opening in their mouth and ask them to blow out the plunger
306
causes of broad complex irregular tacky
torsades (polymorphic vt) af with LBBB VF = pulseless
307
causes of broad complex regular tacky
vt avrt antidromic SVT with BBB
308
causes of narrow complex regular tachy
sinus tachy avnrt avrt orthodromic atrial flutter
309
why would you avoid amiodarone in young people
guaranteed to get SE if on it long enough, use sotalol in AF instead (an atypical beta blocker)
310
AF rate control
any beta blocker except sotalol as this is rhythm control. | if you can't use bb then use non dihydro CCB pref diltiazem
311
use of digoxin in AF
negatively chronotrophic positively inotropic so good in AF in heart failure.
312
when is chadswasc not relevant in AF
in AF with mitral valve disease, their risk is automatically 20% so you anticoagulant.
313
treatment of bradycardia
1- adverse features ? if yes - atropine 500micrograms IV then assess for satisfactory response. if there is then move on as if there were no adverse features, if it fails to respond then move to interim measures. if no - is there a risk of asystole? (recent asystole, mobitz type 2, complete heart block with wide QRS, ventricular pause over 3secs) - if no then observe, if yes move to interim measures. - interim measures - 1- repeat IV atropine 500 micrograms up to 3g max. 2- isoprenaline 5micrograms per min IV 3- adrenaline 2-10 micrograms per min IV 4 - alternative drugs such as aminophylline, dopamine, glucagon (if beta blocker or CCB overdose), glycopyrrolate instead of atropine. alternatively - transcutaneous pacing. if all options fail seek expert help and arrange transvenous pacing
314
antidote for beta blocker overdose
glucagon
315
CCB overdose
``` IV calcium (chloride or gluconate, whichever) second line is insulin, acts as positive inotrope. ```
316
surgical cut off for a AAA
Rupture is a potentially lethal consequence of an abdominal aortic aneurysm. The risk of rupture is generally considered to high once its diameter is > 5.5cm and so treatment is usually deferred until then when the risks of no surgery outweigh the risks of surgery. For aneurysms
317
fever and murmur = ? | causes?
Fever + Murmur = Infective Endocarditis until proven otherwise. causes: a) E.Faecalis is associated with genitourinary disease b) The HACEK group are gram negative coccobacilli and account for ~3% of the total cases of infective endocarditis. c) Staph. Aureas is common in IVDU users d) Iron Deficiency Anaemia + Weight Loss = Colon Cancer until proven otherwise. Streptococcus Bovis is associated with bowel cancer. e) Strep. Viridans is associated with dental procedures and Strep. epidermidis within the first year of valve replacements.
318
how does adenosine work in SVTs
blocks or reduces AVN conduction .
319
difference between AVRT and AVNRT
The clues here are in the ECG and the fact that the tachycardia resolves with adenosine. Inverted P waves in the inferior leads are suggestive of retrograde atrial conduction. This phenomenon is common to junctional tachycardias, which would also fi t with the patient—the fact that she has had them before—and the fact that it resolves once the AV node is blocked by adenosine. Junctional tachycardias originate from the region of the AV node. They are either atrioventricular re-entrant tachycardias (AVRTs) or atrioventricular nodal re-entry tachycardias (AVNRTs). AVNRTs are the most common, usually aff ecting young, healthy individuals with no organic heart disease. They are caused by having two distinct pathways in the region of the AV node—a fast and a slow one. In AVRT, there is an accessory pathway that actually bypasses the AV node and activates the ventricles prematurely. The most common type is Wolff –Parkinson–White syndrome.
320
which MIs cause bradycardia
``` This man has had a myocardial infarction (MI) and is bradycardic. The most likely cause of bradycardia is an inferior MI as, in 60% of cases, the RCA supplies the sinoatrial (SA) node (the LCA supplying the other 40%). ```
321
management of a regular broad complex tachycardia
The ECG shows a regular broad complex tachycardia. Guidelines state that if the patient is not cardiovascularly compromised—as in this case where he is maintaining a good blood pressure—the fi rst-line treatment is amiodarone 300mg as a loading dose, followed by 900mg over the course of the next 24h. In those that are compromised (chest pain, signs of heart failure, systolic BP
322
a patient is referred to you over the phone due to developing palpitations, what do you need to do ?
When the doctor receives the phone call from the ward about this patient, it is vital that he establishes immediately whether the palpitations are causing her haemodynamic compromise. He can do this by checking for the presence of any of the following four factors: 1. Systolic BP 150bpm If any are present, then he should be heading to the ward directly. It would also be wise to alert a senior doctor as the patient will certainly need treatment, possibly even sedation and direct current (DC) cardioversion.
323
cause of collapsing pulse
A collapsing or ‘waterhammer’ pulse is found in aortic incompetence and is more likely to present with breathlessness or heart failure.
324
cause of irregularly irregular pulse
This describes atrial fi brillation or a regular output punctuated by multiple ectopics: an ECG would help to differentiate the two. This is the best diff erential diagnosis as it can present with faintness, but would be more likely also to cause palpitations.
325
interpretation and Ix of corneal Marcus
The image shows corneal arcus, a sign—especially in those under 60—of hyperlipidaemia (in those over 60 it can be a normal fi nding). The key is finding the cause of the high lipid levels. If they are primary, then they will need treatment—initially with lifestyle measures and then with medications. However, it is important to fi rst rule out secondary causes of hyperlipidaemia, i.e. liver, kidney, and thyroid disease.
326
how does budd-chiari tend to present
This can present with ascites and abdominal pain but symptoms and signs of liver failure including hepatomegaly would be expected.
327
peripheral oedema in someone with COPD
This lady has cor pulmonale or right ventricular failure due to chronic hypoxic pulmonary vasoconstriction. Right ventricular hypertrophy, raised right atrial pressures (raised JVP), and raised systemic venous pressure can cause ascites and peripheral oedema. Peripheral oedema in someone with COPD should always prompt assessment of right heart function.
328
initial management of complete heart block
Treatment of complete heart block depends on the site of the block. When the atrial rhythm is not conducted, the ventricular rhythm that is seen is an ‘escape’ rhythm. The width of the QRS complex refl ects where the escape has been generated from. If it is from above the bundle of His, the complex is narrow, the escape rhythm coming from a junctional pacemaker at a rate of 45–60bpm. These patients are usually haemodynamically stable and may respond to medical therapy such as atropine. If the rhythm comes from below the bundle of His, the complex is wide at a rate of
329
management of heart failure due to anaemia
This is symptomatic anaemia (Hb usually
330
why is adenosine used in atrial flutter
Adenosine is used in atrial fl utter (depicted here with 2:1 block) as it causes a transient heart block at the AV node, slows the ventricles, and reveals the underlying atrial rhythm.
331
what is Kussmaul's sign?
A 30-year-old man has been involved in a road traffi c accident. He has sustained injuries to the chest wall and is short of breath. A trauma series of X-rays suggests fl uid in the pleura and pericardium. This is confi rmed by a transthoracic echocardiogram. The JVP rises with inspiration. This paradoxical rise is Kussmaul’s sign. Anything—any sort of fl uid or an abnormal pericardium (in this case, a pericardial eff usion)—that stops the heart from expanding during inspiration also stops the jugular venous pulse from falling as it should
332
A 53-year-old man has felt increasingly tired for the last month. He has had mild pain in his abdomen, which he feels is slightly fuller than normal. He says he has ‘heart valve problems’. There is a pansystolic murmur, heard best at the left sternal edge. what's happening?
This is tricuspid regurgitation causing tender hepatomegaly. A pansystolic murmur is found with mitral and tricuspid regurgitation and ventricular septal defects. The ‘v’ wave occurs towards the end of the pulse and represents atrial fi lling against a closed tricuspid valve. RV heave is usually caused by RV hypertrophy and causes the examining hand to be forced off the chest wall during systole
333
what does this mean - C Prominent ‘a’ wave in JVP + widely split S 2
The ‘a’ wave represents atrial systole and occurs just before the carotid pulsation. Prominence is seen in pulmonary hypertension/stenosis. A widely split S 2 is seen when A2 occurs early or P2 is delayed, as in this case where the most likely cause is pulmonary stenosis.
334
what does this mean? E Tapping apex beat + malar fl ush
E A palpable fi rst heart sound and facies are typical of mitral stenosis.
335
management of paroxysmal AF
In patients who have paroxysmal atrial fi brillation (AF), guidance is that a ‘pill in pocket’ strategy (i.e. a medicine to be taken as required) should be considered if the following criteria are met: There is no history of left ventricular dysfunction, or valvular or ischaemic heart disease. There are infrequent symptomatic episodes of paroxysmal AF. Systolic BP >100mmHg and resting HR >70bpm. Patients can understand how and when to take the medication. Flecainide is a class Ic anti-arrhythmic agent and can be used in this way due to its rapidity of action. Studies have shown that it is eff ective in 80% of arrhythmic episodes in those with paroxysmal AF and so reduces the need for hospitalization. A Amiodarone can be used if beta-blockers have been unable to suppress paroxysms in those with poor left ventricular function. B Digoxin is not used in paroxysmal AF but as a rate control in permanent AF for ‘sedentary’ patients. ``` D Metoprolol (or another ‘standard’ beta -blocker) would be the fi rst choice in paroxysmal AF where a pill-in-the-pocket strategy is not thought appropriate. ``` E Sotalol would be the next choice after a standard beta -blocker if suppression of symptoms has not been achieved
336
first steps in extreme hypertension
In severe hypertension, it is vital to establish whether the raised blood pressure is causing end-organ dysfunction, as, if it is, it will need emergency treatment. This is obvious in cases of myocardial infarction, pulmonary oedema, and aortic dissection, but can be present in rather more covert ways. One of these is hypertensive encephalopathy, which classically presents with a headache, change in consciousness, and some minor neurological dysfunction. In this case, therefore, the junior doctor should establish over the phone whether the patient has a headache: if she does, then he should head directly to the ward to perform an urgent assessment of her Glasgow Coma Scale (GCS) score, neurology, and fundi.
337
A central venous pressure (CVP) line is inserted for fl uid resuscitation of a patient with left ventricular failure and acute renal failure. Which single X-ray fi nding is most likely to confi rm correct placement of the line?
C The line tip is between the fi rst and third sternocostal joints This is a common task for the on-call junior doctor. A post-insertion X-ray should always be requested to check for two main things: (i) that there are no complications from the procedure and (ii) that the line is lying in the correct place for use. The most common immediate complication that can be screened for on an X-ray is a pneumothorax. If the junior doctor is happy that there are no intrapleural slivers of air and he or she can confi rm that the line tip lies between the fi rst and third sternocostal joints—i.e. in the superior vena cava—then he or she can say that there have been no immediate complications from the procedure and that the line is lying in the correct place ready for use.
338
A 62-year-old man has collapsed. He had felt fi ne beforehand apart from a fl uttering feeling in his chest. He turned very pale as he fell to the ground, but within seconds his face fl ushed and full consciousness was regained. This has happened on two previous occasions. what has happened and rx?
The history recounts a series of Stokes–Adams attacks. These are transient bradycardias due to lack of conduction through the atrioventricular (AV) node causing decreased cardiac output and loss of consciousness. The ECG shows a lack of correlation between the P waves and the QRS complexes, and a ventricular rate of 25–30/min. Emergency treatment involves continuous cardiac monitoring and transcutaneous pacing with a view to the placement of a defi nitive transvenous pacemaker, even if the patient is asymptomatic.
339
how does flecainide work
This acts on the His–Purkinje system and is therefore used in the treatment of many supraventricular tachycardias.
340
what are hypertensive emergencies/urgencies
Treating severe hypertension is a common but diffi cult clinical problem. The key to management is to appreciate the actual eff ect that the raised blood pressure is having. If the blood pressure is causing end-organ dysfunction, then it can be said to represent a hypertensive emergency; if it is not, then it is termed a hypertensive urgency. There are certain situations that are indicative of end-organ damage and, therefore, an emergency: Acute myocardial infarction/unstable angina Acute pulmonary oedema Acute renal failure Acute aortic dissection Hypertensive encephalopathy Eclampsia. The aim in emergencies is to stop ongoing end-organ damage. The most eff ective way of doing this (without dropping the blood pressure too quickly and adversely aff ecting cerebral perfusion) is via controlled IV therapy (labetalol is recommended), with the aim of reducing the diastolic blood pressure by 10–15%. A slower approach can be taken in urgencies with the aim of reducing the blood pressure gradually over a couple of days. The use of sublingual therapies such as nifedipine has been condemned due to the seriousness of adverse events reported due to the uncontrolled way in which it drops blood pressure.
341
digoxin clearance issues
Digoxin is cleared both renally and metabolically. Chronic cardiac failure and hypothyroidism reduce the effi cacy of clearance, leading to elevated levels. Drugs such as amiodarone, verapamil, and quinidine have the same eff ect and should prompt a reduction in digoxin dose once started to avoid precipitating toxic levels
342
when is cardiac resynchronisation therapy used in heart failure
If symptoms persist or even worsen, despite optimal medical therapy, then a cardiologist may consider the need for resynchronization therapy. This is essentially a biventricular pacemaker that co-ordinates the action of the right and left ventricles. There are various inclusion criteria, including the left ventricular ejection fraction and the width of the QRS complex.
343
rx of a A regular narrow complex tachycardia
A regular narrow complex tachycardia should initially be treated with a vagal manoeuvre. This increases vagal tone at the atrioventricular (AV) node in order to prevent conduction of impulses from the atria. In order of eff ectiveness these include the Valsalva manoeuvre, carotid sinus massage, and the ‘diving refl ex’, where the patient’s face is submerged in cold water or covered with a towel soaked in cold water
344
difference in the use of synchronised or asynchronous shocks in cardiac arrhythmias
Regardless of the cause of the tachyarrhythmia, signs that the patient is unstable include: (i) chest pain; (ii) signs of heart failure; (iii) reduced consciousness level; and (iv) systolic BP
345
effect of thiazides on blood glucose
Thiazide diuretics can aff ect blood glucose control by decreasing both insulin secretion and peripheral insulin sensitivity. They can also lead to electrolyte imbalance, especially hypokalaemia, particularly in patients who have hepatic and renal impairment.
346
Angina pectoris: drug management
The management of stable angina comprises lifestyle changes, medication, percutaneous coronary intervention and surgery. NICE produced guidelines in 2011 covering the management of stable angina Medication all patients should receive aspirin and a statin in the absence of any contraindication sublingual glyceryl trinitrate to abort angina attacks NICE recommend using either a beta-blocker or a calicum channel blocker first-line based on 'comorbidities, contraindications and the person's preference' if a calcium channel blocker is used as monotherapy a rate-limiting one such as verapamil or diltiazem should be used. If used in combination with a beta-blocker then use a long-acting dihydropyridine calcium-channel blocker (e.g. modified-release nifedipine). Remember that beta-blockers should not be prescribed concurrently with verapamil (risk of complete heart block) if there is a poor response to initial treatment then medication should be increased to the maximum tolerated dose (e.g. for atenolol 100mg od) if a patient is still symptomatic after monotherapy with a beta-blocker add a calcium channel blocker and vice versa if a patient is on monotherapy and cannot tolerate the addition of a calcium channel blocker or a beta-blocker then consider one of the following drugs: a long-acting nitrate, ivabradine, nicorandil or ranolazine if a patient is taking both a beta-blocker and a calcium-channel blocker then only add a third drug whilst a patient is awaiting assessment for PCI or CABG Nitrate tolerance many patients who take nitrates develop tolerance and experience reduced efficacy the BNF advises that patients who develop tolerance should take the second dose of isosorbide mononitrate after 8 hours, rather than after 12 hours. This allows blood-nitrate levels to fall for 4 hours and maintains effectiveness this effect is not seen in patients who take modified release isosorbide mononitrate Ivabradine a new class of anti-anginal drug which works by reducing the heart rate acts on the If ('funny') ion current which is highly expressed in the sinoatrial node, reducing cardiac pacemaker activity adverse effects: visual effects, particular luminous phenomena, are common. Bradycardia, due to the mechanism of action, may also be seen there is no evidence currently of superiority over existing treatments of stable angina
347
which beta blockers have an evidence base for reducing mortality in heart failure
Both carvedilol and bisoprolol have been shown to reduce mortality in stable heart failure. The other beta-blockers have no evidence base to support their use. NICE recommend that all heart failure patients should take both an ACE-inhibitor and a beta-blocker.
348
what thiazide diuretics are now used in hypertension | ACD
Step 3 treatment add a thiazide diuretic (D, i.e. A + C + D) NICE now advocate using either chlorthalidone (12.5-25.0 mg once daily) or indapamide (1.5 mg modified-release once daily or 2.5 mg once daily) in preference to a conventional thiazide diuretic such as bendroflumethiazide thiazide-like
349
what meds do you give if A+C+D doesn't control a persons hypertension
NICE define a clinic BP >= 140/90 mmHg after step 3 treatment with optimal or best tolerated doses as resistant hypertension. They suggest step 4 treatment or seeking expert advice Step 4 treatment consider further diuretic treatment if potassium 4.5 mmol/l add higher-dose thiazide-like diuretic treatment if further diuretic therapy is not tolerated, or is contraindicated or ineffective, consider an alpha- or beta-blocker Patients who fail to respond to step 4 measures should be referred to a specialist
350
Peri-arrest rhythms: bradycardia
As this gentleman is presenting with atrial fibrillation (as seen by palpitations and absent P waves on ECG), the options for management include rate or rhythm control, with the possibility of thromboprophylaxis. However, as he has an unmeasurable BP and signs of haemodynamic instability, he is acutely unwell and so his arrhythmia must be treated as soon as possible with DC cardioversion without delaying for thromboprophylaxis. Anticoagulation should be continued for 4 weeks after cardioversion however. If he was clinically stable and had atrial fibrillation of over 48 hours duration, the risk of stroke would mean parenteral anticoagulation would take precedence over cardioversion. (source: NICE, https://www.nice.org.uk/guidance/cg180) Peri-arrest rhythms: bradycardia The 2010 Resuscitation Council (UK) guidelines emphasise that the management of bradycardia depends on: 1. identifying the presence of signs indicating haemodynamic compromise - 'adverse signs' 2. identifying the potential risk of asystole Adverse signs The following factors indicate haemodynamic compromise and hence the need for treatment: shock: hypotension (systolic blood pressure 3 seconds If there is a delay in the provision of transvenous pacing the following interventions may be used: atropine, up to maximum of 3mg transcutaneous pacing adrenaline infusion titrated to response
351
how to reverse LMWH overdose
Protamine sulfate is a drug that reverses the anticoagulant effects of heparin by binding to it.
352
ECG features of HOCM
``` ECG left ventricular hypertrophy progressive T wave inversion deep Q waves atrial fibrillation may occasionally be seen ``` Sudden death, unusual collapse in young person - ? HOCM In this age group hypertrophic obstructive cardiomyopathy would be a more common cause of the murmur/recurrent collapse than aortic stenosis.
353
use of thrombolysis in STEMI
Primary percutaneous coronary intervention (PCI) has emerged as the gold-standard treatment for STEMI but is not available in all centres. Thrombolysis should be performed in patients without access to primary PCI With regards to thrombolysis: tissue plasminogen activator (tPA) has been shown to offer clear mortality benefits over streptokinase tenecteplase is easier to administer and has been shown to have non-inferior efficacy to alteplase with a similar adverse effect profile An ECG should be performed 90 minutes following thrombolysis to assess whether there has been a greater than 50% resolution in the ST elevation if there has not been adequate resolution then rescue PCI is superior to repeat thrombolysis for patients successfully treated with thrombolysis PCI has been shown to be beneficial. The optimal timing of this is still under investigation
354
ECG presentation of a posterior MI
Deep ST depression in V1-V3 with tall T waves is a sign of a severe posterior myocardial infarction. These patients should be treated as a STEMI. If you were to place posterior leads on the back of the patient and re do the ECG you would see ST elevation. Therefore the patient should be treated with primary percutaneous coronary intervention.
355
Acute coronary syndrome: management of NSTEMI
All patients should receive: 1 - aspirin 300mg 2 - nitrates or morphine to relieve chest pain if required 3 - Antithrombin treatment. Fondaparinux should be offered to patients who are not at a high risk of bleeding and who are not having angiography within the next 24 hours. If angiography is likely within 24 hours or a patients creatinine is > 265 µmol/l unfractionated heparin should be given. 4 - Clopidogrel 300mg should be given to all patients and continued for 12 months. 5 - Intravenous glycoprotein IIb/IIIa receptor antagonists (eptifibatide or tirofiban) should be given to patients who have an intermediate or higher risk of adverse cardiovascular events (predicted 6-month mortality above 3.0%), and who are scheduled to undergo angiography within 96 hours of hospital admission. 6 - Coronary angiography should be considered within 96 hours of first admission to hospital to patients who have a predicted 6-month mortality above 3.0%. It should also be performed as soon as possible in patients who are clinically unstable. The 2008 British Thoracic Society oxygen therapy guidelines advise not giving oxygen unless the patient is hypoxic.
356
Patent ductus arteriosus | overview
Overview acyanotic congenital heart defect connection between the pulmonary trunk and descending aorta more common in premature babies, born at high altitude or maternal rubella infection in the first trimester ``` Features left subclavicular thrill continuous 'machinery' murmur large volume, bounding, collapsing pulse wide pulse pressure heaving apex beat ```
357
Patent ductus arteriosus | managemnet
Management indomethacin closes the connection in the majority of cases if associated with another congenital heart defect amenable to surgery then prostaglandin E1 is useful to keep the duct open until after surgical repair
358
what is Brugada Syndrome
Brugada Syndrome is an ECG abnormality with a high incidence of sudden death in patients with structurally normal hearts. There’s really only one type of Brugada syndrome. Diagnosis depends on a characteristic ECG finding AND clinical criteria. Further risk stratification is controversial. Definitive treatment = ICD. Brugada sign in isolation is of questionable significance. In a nutshell, Brugada syndrome is due to a mutation in the cardiac sodium channel gene. This is often referred to as a sodium channelopathy. Over 60 different mutations have been described so far and at least 50% are spontaneous mutations, but familial clustering and autosomal dominant inheritance has been demonstrated. ECG changes can be transient with Brugada syndrome and can also be unmasked or augmented by multiple factors Type 1 (Coved ST segment elevation >2mm in >1 of V1-V3 followed by a negative T wave) is the only ECG abnormality that is potentially diagnostic. This has been referred to as Brugada sign This ECG abnormality must be associated with one of the following clinical criteria to make the diagnosis: Documented ventricular fibrillation (VF) or polymorphic ventricular tachycardia (VT). Family history of sudden cardiac death at
359
Management
Management IV bicarbonate may reduce the risk of seizures and arrhythmias in severe toxicity arrhythmias: class 1a (e.g. Quinidine) and class Ic antiarrhythmics (e.g. Flecainide) are contraindicated as they prolong depolarisation. Class III drugs such as amiodarone should also be avoided as they prolong the QT interval. Response to lignocaine is variable and it should be emphasized that correction of acidosis is the first line in management of tricyclic induced arrhythmias intravenous lipid emulsion is increasingly used to bind free drug and reduce toxicity dialysis is ineffective in removing tricyclics
360
Prosthetic heart valves - antithrombotic therapy:
Prosthetic heart valves - antithrombotic therapy: bioprosthetic: aspirin mechanical: warfarin + aspirin
361
Heart failure: acute management
The patient is suffering from severe pulmonary oedema with bilateral course crackles and cough productive of white sputum. The patient has signs of right sided heart failure with raised JVP and peripheral oedema. They also have a history of MI and hypertension that are two risk factors for heart failure. NICE guidance on Acute Heart Failure 2014 states that a patient who has failed medical management of pulmonary oedema with severe dyspnoea should be considered for CPAP. BIPAP is not used in acute pulmonary oedema. Heart failure: acute management ``` Management options in acute heart failure include: oxygen diuretics opiates vasodilators inotropic agents CPAP ultrafiltration mechanical circulatory assistance: e.g. intra-aortic balloon counterpulsation or ventricular assist devices ``` Consideration should be given to discontinuing beta-blockers in the short-term.
362
what is a J wave
'J' wave - small hump at the end of the QRS complex seen i hypothermia
363
features and associations of mitral valve prolapse
Whilst some patients with acromegaly have mitral valve prolapse (MVP) it is not a common association. It should be remembered that the prevalence of MVP in a standard population is around 5-10% Mitral valve prolapse Mitral valve prolapse is common, occurring in around 5-10 % of the population. It is usually idiopathic but may be associated with a wide variety of cardiovascular disease and other conditions ``` Associations congenital heart disease: PDA, ASD cardiomyopathy Turner's syndrome Marfan's syndrome, Fragile X osteogenesis imperfecta pseudoxanthoma elasticum Wolff-Parkinson White syndrome long-QT syndrome Ehlers-Danlos Syndrome polycystic kidney disease ``` Features patients may complain of atypical chest pain or palpitations mid-systolic click (occurs later if patient squatting) late systolic murmur (longer if patient standing) complications: mitral regurgitation, arrhythmias (including long QT), emboli, sudden death
364
how does tPa work
Thrombolytic drugs activate plasminogen to form plasmin. This in turn degrades fibrin and help breaks up thrombi. They in primarily used in patients who present with a ST elevation myocardial infarction. Other indications include acute ischaemic stroke and pulmonary embolism, although strict inclusion criteria apply.
365
A 72-year-old woman is reviewed. Three months ago she was diagnosed as being in fast atrial fibrillation after being found to have an irregular heart rate of 123/min. She was started on bisoprolol and warfarin. Despite titrating the bisoprolol to the maximum dose her heart rate is recorded at 94/min. The patient has no other past medical history of note. Cardiorespiratory examination is normal other than the heart rate of 94/min. Her blood pressure is 126/80 mmHg. What is the most appropriate next step in management?
In this situation NICE recommend either adding diltiazem or digoxin.
366
One day following a thrombolysed inferior myocardial infarction a 72-year-old man develops signs of left ventricular failure. His blood pressure drops to 100/70mmHg. On examination he has a new early-to-mid systolic murmur.
The correct answer is Papillary muscle rupture This patient has developed acute mitral regurgitation secondary to papillary muscle rupture. The differential diagnosis is ventricular septal rupture.
367
Primary hyperaldosteronism
Conn's syndrome is the likely diagnosis - a renin:aldosterone ratio would be an appropriate first-line investigation. A normal clinical examination makes a diagnosis of Cushing's syndrome less likely Primary hyperaldosteronism Primary hyperaldosteronism was previously thought to be most commonly caused by an adrenal adenoma, termed Conn's syndrome. However, recent studies have shown that bilateral idiopathic adrenal hyperplasia is the cause in up to 70% of cases. Differentiating between the two is important as this determines treatment. Adrenal carcinoma is an extremely rare cause of primary hyperaldosteronism Features hypertension hypokalaemia (e.g. muscle weakness) alkalosis ``` Investigations high serum aldosterone low serum renin high-resolution CT abdomen adrenal vein sampling ``` Management adrenal adenoma: surgery bilateral adrenocortical hyperplasia: aldosterone antagonist e.g. spironolactone
368
PT with hypertension cannot tolerate a CCB, what do you do?
This patient has developed ankle oedema after being started on amlodipine. Oedema is listed as one of the most common side-effects of amlodipine in the BNF. In this situation NICE advise ' If a calcium channel blocker is not suitable, for example because of oedema or intolerance, or if there is evidence of heart failure or a high risk of heart failure, offer a thiazide-like diuretic.' eg indapamide
369
control of angina if not adequately controlled with beta-blocker monotherapy
NICE guidelines recommend adding a calcium channel blocker for angina which is not adequately controlled with beta-blocker monotherapy. Verapamil is contraindicated whilst taking a beta-blocker and diltiazem should be used with caution due to the risk of bradycardia.
370
blood pressure targets for hypertensives
Clinic BP ABPM / HBPM | Age 80 years 150/90 mmHg 145/85 mmHg
371
what are hyper acute T waves
The T waves in V2 + V3 are very large or 'hyperacute' to use the cardiology lingo. This is often the first change seen with myocardial ischaemia. This patients ECG 30 minutes later is shown below: STEMI basically this person had hyper acute T waves and i missed that. the just looked really big and in one vessel territory. should have admitted to hospital
372
when do you not give clopidogrel to a patient with a STEMI
if the are out of hospital. give them the aspirin and GTN but NICE say no clopidogrel until in hospital
373
ECG: digoxin
Firstly, exam technique - we can discount verapamil - this lady has heart failure and would not be prescribed a drug which has such strong negative inotropic effects. The above ECG shows slow atrial fibrillation. A beta-blocker overdose may explain the bradycardia but not give the characteristic ECG changes seen here - 'scooped' or 'reverse tick' ST depression in I and aVL and a short QTc interval. ECG: digoxin ``` ECG features down-sloping ST depression ('reverse tick') flattened/inverted T waves short QT interval arrhythmias e.g. AV block, bradycardia ```
374
diagnosis of hypertension in those over the age of 80
NICE now only recommend diagnosing people over the age of 80 years as hypertensive if they have stage 2 hypertension (ABPM daytime average or HBPM average BP >= 150/95 mmHg).
375
Atrial fibrillation: post-stroke
NICE issued guidelines on atrial fibrillation (AF) in 2006. They included advice on the management of patients with AF who develop a stroke or transient-ischaemic attack (TIA). Recommendations include: following a stroke or TIA warfarin should be given as the anticoagulant of choice. Aspirin/dipyridamole should only be given if needed for the treatment of other comorbidities in acute stroke patients, in the absence of haemorrhage, anticoagulation therapy should be commenced after 2 weeks. If imaging shows a very large cerebral infarction then the initiation of anticoagulation should be delayed
376
person has an SVT, when can you NOT give adenosine
The administration of adenosine is contraindicated by her history of asthma. Verapamil should therefore be given.
377
overview of aortic dissection management
Aortic dissection type A - ascending aorta - control BP(IV labetalol) + surgery type B - descending aorta - control BP(IV labetalol)
378
Myocarditis causes and presentation
Myocarditis is an acute inflammatory condition of the heart which often occurs in patients with no underlying cardiac disease. Clinical features include chest pain (usually due to co-existant pericarditis), acute heart failure and arrhythmias. While the most common aetiology in Europe is viral, the most common cause worldwide is Trypanosoma cruzi (Chaga's disease). Myocarditis ``` Causes viral: coxsackie, HIV bacteria: diphtheria, clostridia spirochaetes: Lyme disease protozoa: Chagas' disease, toxoplasmosis autoimmune drugs: doxorubicin ``` Presentation usually young patient with acute history chest pain, SOB
379
The key differences between constrictive pericarditis and cardiac tamponade are summarised in the table below:
Cardiac tamponade Constrictive pericarditis JVP: Absent Y descent X + Y present Pulsus paradoxus: Present Absent Kussmaul's sign: Rare Present Characteristic features : none, Pericardial calcification on CXR
380
Renal vascular disease
Flash pulmonary oedema, U&Es worse on ACE inhibitor, asymmetrical kidneys → renal artery stenosis - do MR angiography Renal artery stenosis may cause sudden onset or 'flash' pulmonary oedema. A myocardial infarction is unlikely given the normal ECG and cardiac enzymes. Chest pain would also be expected in a 55-year-old patient with no history of diabetes. Fibromuscular dysplasia is generally seen in young woman. Renal vascular disease Renal vascular disease is most commonly due to atherosclerosis (> 95% of patients). It is associated with risk factors such as smoking and hypertension that cause atheroma elsewhere in the body. It may present as hypertension, chronic renal failure or 'flash' pulmonary oedema. In younger patients however fibromuscular dysplasia (FMD) needs to be considered. FMD is more common in young women and characteristically has a 'string of beads' appearance on angiography. Patients respond well to balloon angioplasty Investigation MR angiography is now the investigation of choice CT angiography conventional renal angiography is less commonly performed used nowadays, but may still have a role when planning surgery
381
NICE NSTEMI/unstable angina guidelines are based on 6 month mortality risk:
NICE NSTEMI/unstable angina guidelines are based on 6 month mortality risk: if > 1.5% clopidogrel for 12 months if > 3% angiography within 96 hours
382
Myocardial infarction: secondary prevention
All patients should be offered the following drugs: dual antiplatelet therapy (aspirin plus a second antiplatelet agent) ACE inhibitor beta-blocker statin Some selected lifestyle points: diet: advise a Mediterranean style diet, switch butter and cheese for plant oil based products. Do not recommend omega-3 supplements or eating oily fish exercise: advise 20-30 mins a day until patients are 'slightly breathless' sexual activity may resume 4 weeks after an uncomplicated MI. Reassure patients that sex does not increase their likelihood of a further MI. PDE5 inhibitors (e.g, sildenafil) may be used 6 months after a MI. They should however be avoided in patient prescribed either nitrates or nicorandil Clopidogrel since clopidogrel came off patent it is now much more widely used post-MI STEMI: the European Society of Cardiology recommend dual antiplatelets for 12 months. In the UK this means aspirin + clopidogrel non-ST segment elevation myocardial infarction (NSTEMI): following the NICE 2013 Secondary prevention in primary and secondary care for patients following a myocardial infarction guidelines clopidogrel should be given for the first 12 months Aldosterone antagonists patients who have had an acute MI and who have symptoms and/or signs of heart failure and left ventricular systolic dysfunction, treatment with an aldosterone antagonist licensed for post-MI treatment (e.g. eplerenone) should be initiated within 3-14 days of the MI, preferably after ACE inhibitor therapy
383
Amiodarone
A baseline chest x-ray is required due to the risk of pulmonary fibrosis / pneumonitis in patients treated with amiodarone. Urea and electrolytes are suggested by the BNF to detect hypokalaemia which may increase the risk of arrhythmias developing. Amiodarone Amiodarone is a class III antiarrhythmic agent used in the treatment of atrial, nodal and ventricular tachycardias. The main mechanism of action is by blocking potassium channels which inhibits repolarisation and hence prolongs the action potential. Amiodarone also has other actions such as blocking sodium channels (a class I effect) The use of amiodarone is limited by a number of factors long half-life (20-100 days) should ideally be given into central veins (causes thrombophlebitis) has proarrhythmic effects due to lengthening of the QT interval interacts with drugs commonly used concurrently e.g. Decreases metabolism of warfarin numerous long-term adverse effects (see below) Monitoring of patients taking amiodarone TFT, LFT, U&E, CXR prior to treatment TFT, LFT every 6 months ``` Adverse effects of amiodarone use thyroid dysfunction corneal deposits pulmonary fibrosis/pneumonitis liver fibrosis/hepatitis peripheral neuropathy, myopathy photosensitivity 'slate-grey' appearance thrombophlebitis and injection site reactions bradycardia ```
384
Which one of the following treatments is not appropriate in the management of Wolff-Parkinson White?
Verapamil and digoxin should be avoided in patients with Wolff-Parkinson White as they may precipitate VT or VF
385
ECG: bi/tri-fascicular block
The ECG shows both right bundle branch block and left axis deviation indicating bifascicular block. ECG: bi/tri-fascicular block Bifascicular block combination of RBBB with left anterior or posterior hemiblock e.g. RBBB with left axis deviation Trifascicular block features of bifascicular block as above + 1st degree heart block
386
Rheumatic fever: criteria
Rheumatic fever develops following an immunological reaction to recent (2-6 weeks ago) Streptococcus pyogenes infection. Diagnosis is based on evidence of recent streptococcal infection accompanied by: 2 major criteria 1 major with 2 minor criteria ``` Evidence of recent streptococcal infection ASOT > 200iu/mL history of scarlet fever positive throat swab increase in DNase B titre ``` ``` Major criteria erythema marginatum Sydenham's chorea polyarthritis carditis (endo-, myo- or peri-) subcutaneous nodules ``` ``` Minor criteria raised ESR or CRP pyrexia arthralgia (not if arthritis a major criteria) prolonged PR interval ```
387
what is MUGA and when is it used
MUGA Multi Gated Acquisition Scan, also known as radionuclide angiography radionuclide (technetium-99m) is injected intravenously the patient is placed under a gamma camera may be performed as a stress test can accurately measure left ventricular ejection fraction. Typically used before and after cardiotoxic drugs are used
388
what is BNP and what is it used for
B-type natriuretic peptide B-type natriuretic peptide (BNP) is a hormone produced mainly by the left ventricular myocardium in response to strain. Whilst heart failure is the most obvious cause of raised BNP levels any cause of left ventricular dysfunction such as myocardial ischaemia or valvular disease may raise levels. Raised levels may also be seen due to reduced excretion in patients with chronic kidney disease. Factors which reduce BNP levels include treatment with ACE inhibitors, angiotensin-2 receptor blockers and diuretics. Effects of BNP vasodilator diuretic and natriuretic suppresses both sympathetic tone and the renin-angiotensin-aldosterone system Clinical uses of BNP Diagnosing patients with acute dyspnoea a low concentration of BNP(400) carry poor prognosis. In these cases 2 week wait for urgent echocardiography and specialist assessment is advised. Although elevated levels of BNP do not confirm the diagnosis of heart failure, normal levels rule the diagnosis out (highly sensitivity but varying specificity). NICE suggest that BNP measurements are not necessary in people with suspected heart failure who have had a previous myocardial infarction. These patients require urgent referral, echocardiography and specialist assessment because if heart failure is present this carries a poor prognosis. Increased BNP levels (>400) are not on their own diagnostic of heart failure, and may be elevated as a result of left ventricular hypertrophy, myocardial ischaemia, atrial fibrillation, pulmonary hypertension, hypoxia, pulmonary embolism, right ventricular strain, chronic obstructive pulmonary disease, liver failure, sepsis, diabetes, and renal impairment. In addition, levels tend to be higher in women, and in people older than 70. Heart failure is unlikely if BNP levels are low (
389
Causes of a loud S2
Causes of a loud S2 hypertension: systemic (loud A2) or pulmonary (loud P2) hyperdynamic states atrial septal defect without pulmonary hypertension
390
Causes of a soft S2
Causes of a soft S2 | aortic stenosis
391
Causes of fixed split S2
Causes of fixed split S2 | atrial septal defect
392
Causes of a widely split S2
``` Causes of a widely split S2 deep inspiration RBBB pulmonary stenosis severe mitral regurgitation ```
393
Causes of a reversed (paradoxical) split S2 (P2 occurs before A2)
``` Causes of a reversed (paradoxical) split S2 (P2 occurs before A2) LBBB severe aortic stenosis right ventricular pacing WPW type B (causes early P2) patent ductus arteriosus ```
394
what group of patients with angina do you not need to risk score as you know they immediately have a risk over 90%?
If patients have typical anginal symptoms and a risk of CAD is greater than 90% then no further diagnostic testing is required. It should be noted that all men over the age of 70 years who have typical anginal symptoms fall into this category.
395
Diabetes mellitus: hypertension management
ACE inhibitors are first-line for hypertension in diabetics, irrespective of the patients age This patient has stage 1 hypertension as defined by NICE. He should however be treated because he has underlying diabetes. The first-line treatment for a patient aged > 55 years is a calcium channel blocker. However, in patients with diabetes ACE inhibitors are used first-line due to their renoprotective effect. Diabetes mellitus: hypertension management NICE recommend the following blood pressure targets for type 2 diabetics: if end-organ damage (e.g. renal disease, retinopathy)
396
Angiodysplasia | diagnosis management associations
The association between angiodysplasia and aortic stenosis is thought to be caused by von Willebrand factor (vWF) being proteolysed in the turbulent blood flow around the aortic valve vWF is most active in vascular beds with high shear stress, such as angiodysplasia, and deficiency of vWF increases the bleeding risk from such lesions Angiodysplasia Angiodysplasia is a vascular deformity of the gastrointestinal tract which predisposes to bleeding and iron deficiency anaemia. There is thought to be an association with aortic stenosis, although this is debated. Angiodysplasia is generally seen in elderly patients Diagnosis colonoscopy mesenteric angiography if acutely bleeding Management endoscopic cautery or argon plasma coagulation antifibrinolytics e.g. Tranexamic acid oestrogens may also be used
397
Causes of long QT syndrome:
Causes of long QT syndrome: 1. Genetic: LQT1 / LQT2 (potassium channel mutation); LQT3 (sodium channel mutation) Jervell and Lange-Nielsen syndrome (associated with deafness) Romano-Ward syndrome 2. Electrolytes: Hypocalcaemia Hypomagnesaemia Hypokalaemia 3. Drugs: Antiarrhythmics (e.g. amioderone, sotalol) Antibiotics (e.g. erythromycin, clarithromycin, ciprofloxacin) Psychotropic drugs (e.g. serotonin reuptake inhibitors, tricyclic antidepressants, neuroleptic agents)
398
dvt diagnosis
If a patient is suspected of having a DVT a two-level DVT Wells score should be performed: Clinical probability simplified score DVT likely: 2 points or more DVT unlikely: 1 point or less If a DVT is 'likely' (2 points or more) a proximal leg vein ultrasound scan should be carried out within 4 hours and, if the result is negative, a D-dimer test if a proximal leg vein ultrasound scan cannot be carried out within 4 hours a D-dimer test should be performed and low-molecular weight heparin administered whilst waiting for the proximal leg vein ultrasound scan (which should be performed within 24 hours) If a DVT is 'unlikely' (1 point or less) perform a D-dimer test and if it is positive arrange: a proximal leg vein ultrasound scan within 4 hours if a proximal leg vein ultrasound scan cannot be carried out within 4 hours low-molecular weight heparin should be administered whilst waiting for the proximal leg vein ultrasound scan (which should be performed within 24 hours)
399
dvt management
Management Low molecular weight heparin (LMWH) or fondaparinux should be given initially after a DVT is diagnosed. a vitamin K antagonist (i.e. warfarin) should be given within 24 hours of the diagnosis the LMWH or fondaparinux should be continued for at least 5 days or until the international normalised ratio (INR) is 2.0 or above for at least 24 hours, whichever is longer, i.e. LMWH or fondaparinux is given at the same time as warfarin until the INR is in the therapeutic range warfarin should be continued for at least 3 months. At 3 months, NICE advise that clinicians should 'assess the risks and benefits of extending treatment' NICE add 'consider extending warfarin beyond 3 months for patients with unprovoked proximal DVT if their risk of VTE recurrence is high and there is no additional risk of major bleeding'. This essentially means that if there was no obvious cause or provoking factor (surgery, trauma, significant immobility) it may imply the patient has a tendency to thrombosis and should be given treatment longer than the norm of 3 months. In practice most clinicians give 6 months of warfarin for patients with an unprovoked DVT/PE for patients with active cancer NICE recommend using LMWH for 6 months
400
Further investigations and thrombophilia screening post dvt
Further investigations and thrombophilia screening As both malignancy and thrombophilia are obvious risk factors for deep vein thrombosis NICE make recommendations on how to investigate patients with unprovoked clots. Offer all patients diagnosed with unprovoked DVT or PE who are not already known to have cancer the following investigations for cancer: a physical examination (guided by the patient's full history) and a chest X-ray and blood tests (full blood count, serum calcium and liver function tests) and urinalysis. Consider further investigations for cancer with an abdomino-pelvic CT scan (and a mammogram for women) in all patients aged over 40 years with a first unprovoked DVT or PE Thrombophilia screening not offered if patients will be on lifelong warfarin (i.e. won't alter management) consider testing for antiphospholipid antibodies if unprovoked DVT or PE consider testing for hereditary thrombophilia in patients who have had unprovoked DVT or PE and who have a first-degree relative who has had DVT or PE